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The American Optometric Association represents approximately 39,000 doctors of optometry, optometry students 
and paraoptometric assistants and technicians. Optometrists serve individuals in nearly 6,500 communities across 
the country, and in 3,500 of those communities are the only eye doctors. Doctors of optometry provide two-thirds of 
all primary eye care in the United States.
Doctors of optometry are on the frontline of eye and vision care. They examine, diagnose, treat, and manage 
diseases and disorders of the eye. In addition to providing eye and vision care, optometrists play a major 
role in an individual’s overall health and well-being by detecting systemic diseases such as diabetes and 
hypertension.
The mission of the profession of optometry is to fulfill the vision and eye care needs of the public through 
clinical care, research, and education, all of which enhance the quality of life.
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Disclaimer 
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intended to assist the clinician in the decision-making process. Patient care and treatment should always be based 
on a clinician’s independent professional judgment, given the patient’s circumstances, and in compliance with state 
laws and regulations. 
The information in this guideline is current to the extent possible at the time of publication. 
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A. WHAT IS THE EVIDENCE-BASED PROCESS? 
As a result of the Medicare Improvement for Patients and Providers Act of 2008, Congress commissioned the 
Secretary of Health and Human Services to create a public-private program to develop and promote a common 
set of standards for the development of clinical practice guidelines (CPGs). These standards address the structure, 
process, reporting, and final products of systematic reviews of comparative effectiveness research and evidence-
based clinical practice guidelines. 
The Institute of Medicine (IOM), now the Health and Medicine Division of the National Academies of Sciences, 
Engineering, and Medicine (NASEM), in response to a request from the Agency for Healthcare Research and Quality 
(AHRQ), issued two reports in March 2011: Clinical Practice Guidelines We Can Trust and Finding What Works in 
Health Care: Standards for Systematic Reviews. 
In Clinical Practice Guidelines We Can Trust,1 the IOM redefined CPGs as follows 
“Clinical practice guidelines are statements that include recommendations intended to optimize patient care that 
are informed by a systematic review of the evidence and an assessment of the benefits and harms of alternative 
care options.” 
The report states that to be trustworthy, guidelines should:
• Be based on a systematic review of existing evidence 
• Be developed by a knowledgeable, multidisciplinary panel of experts and key stakeholders 
• Consider important patient subgroups and preferences, as appropriate 
• Be based on a transparent process that minimizes conflicts of interest and biases
• Provide a clear explanation of the logical relationships between alternative care options and health outcomes
• Provide a grading of both the quality of evidence and the strength of the clinical recommendation
• Be revised as appropriate when new evidence warrants modifications of recommendations.
Based on the IOM/NASEM reports, the American Optometric Association (AOA) Evidence-Based Optometry (EBO) 
Committee developed a 14-step process to meet the new evidence-based recommendations for trustworthy 
guidelines.
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AOA’s 14 Steps to Evidence-Based Clinical Practice Guideline Development
1. Guideline Development Group: Evidence-Based Optometry (EBO) Committee selects a multidisciplinary panel of 
experts, including patient and public representatives, for the Guideline Development Group (GDG).
2. Transparency and COI: GDG manages all conflict of interest (COI), which is documented by AOA staff.
3. Clinical Questions*: GDG explores and defines all clinical questions through a Question Formulation Meeting and 
defines search criteria.
4. Search for Evidence: AOA Staff sends clinical questions for query (outside researchers) and provides all papers to 
the Guideline Development Reading Group (GDRG). There should be no inclusion of Systematic Review (SR) writers in 
the GDRG.
5. Grade Evidence and Clinical Recommendations: Two clinicians from the GDRG read and grade papers, 
randomly selected according to the pre-designed evidence search criteria. They state clinical recommendation(s) from 
each paper and grade the strength of each.
6. Articulate Clinical Recommendations*: GDRG reviews all clinical recommendations and articulates each for 
inclusion in the guideline during an “Articulation of Recommendations” meeting and identified gaps in medical research 
are documented.
7. Write Draft: AOA Staff sends the Articulation results to the writer for development of draft 1.
8. Draft Review and Edits*: GDG reads draft 1, discusses and edits.
9. Rewrite/Final Drafts: AOA Staff sends the draft results to the writer for writing/revisions for draft 2, then sends to 
medical editor for copy editing, then a final review is completed as necessary.
10. Approval for Peer Review: AOA Staff or EBO Committee Chair sends the Peer Review draft to AOA Board of 
Trustees for approval to post for peer and public review. This draft is posted on the AOA website, the review period is 
announced, and comments are solicited.
11. Final Document Produced: GDG reviews all peer review comments and revises the final document (includes peer 
review comments, documents why a peer review comment was not included, or identifies further gaps for review when 
preparing the next edition).
12. Final Draft Approval and Legal Review: AOA Staff or EBO Committee Chair sends to the AOA Board of 
Trustees and AOA Legal Counsel for approval that the GDG followed the evidence-based process as outlined by the 
IOM and AOA EBO Committee (same management of COI).
13. Post Guidelines: AOA Staff posts the evidence-based guideline to AOA website and submits it to the National 
Guideline Clearinghouse for public use, accompanied by AOA’s written process and documents.  
14. Schedule Reviews: GDG reviews all previously identified gaps in medical research and any new evidence, and 
revises the evidence-based guideline every 2 to 5 years.
**Denotes face-to-face meeting




B. HOW TO USE THIS GUIDELINE 
The following table provides the grading system used in this guideline for rating evidence-based clinical statements. 
Grades are provided for both quality of the evidence and strength of clinical recommendations.
Key to Quality of Evidence and Strength of Clinical Recommendation Grading
Grade Quality of Evidence Levels
A
Data derived from well-designed, randomized clinical trials (RCTs); systematic reviews; meta-analyses; or 
diagnostic studies (Grade A) of relevant populations with a validated reference standard. Grade A diagnostic 
studies do not have a narrow population or use a poor reference standard and are not case control studies of 
diseases or conditions.
B
Randomized clinical trials (RCTs) with weaker designs; cohort studies (retrospective or prospective); or 
diagnostic studies (Grade B). Grade B diagnostic studies have only one of the following: a narrow population, 
or the sample used does not reflect the population to whom the test would apply, or uses a poor reference 
standard, or the comparison between the test and reference standard is not blinded, or are case control studies 
of diseases or conditions. 
C
Studies of strong design, but with substantial uncertainty about conclusions or serious doubts about 
generalizations, bias, research design, or sample size. Nonrandomized trials; case control studies (retrospective 
or prospective); or diagnostic studies (Grade C). Grade C diagnostic studies have at least 2 or more of the 
following: a narrow population, or the sample used does not reflect the population to whom the test would 
apply, or uses a poor reference standard, or the comparison between the test and reference standard is not 
blinded, or are case control studies of diseases or conditions. 
D Cross sectional studies; case reports/series; reviews; position papers; expert opinion; or reasoning from principal. 
Strength of Clinical Recommendation Levels
Strong Recommendation: The benefits of the recommendation clearly exceed the harms (or the harms clearly exceed 
the benefits in the case of a negative recommendation) and the quality of evidence is excellent (Grade A or B). In some 
clearly identified circumstances, a strong recommendation may be made on lesser evidence when high-quality evidence 
is impossible to obtain and the anticipated benefits strongly outweigh the harms.
This recommendation should be followed unless clear and compelling rationale for an alternative approach  
is present.
Recommendation: The benefits of the recommendation exceed the harms (or the harms exceed the benefits in the 
case of a negative recommendation) but the quality of evidence is not as strong (Grade B or C). In some clearly identified 
circumstances, a recommendation may be made on lesser evidence when high-quality evidence is impossible to obtain 
and the anticipated benefits strongly outweigh the harms.
This recommendation should generally be followed, but remain alert for new information.
Option: The benefits of the recommendation exceed the harms (or the harms exceed the benefits in the case of a 
negative recommendation) but the quality of evidence is low (Grade D) or well-done studies (Grade A, B, or C) show little 
clear advantage of one approach versus another. In some clearly identified circumstances, an option may be elevated 
to a recommendation even with lesser evidence when high-quality evidence is impossible to obtain and the anticipated 
benefits strongly outweigh the harms. 
There should be an awareness of this recommendation, but a flexibility in clinical decision-making, as well as 
remaining alert for new information.
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Clinical Notes and Statements  
Quality of evidence grades (A, B, C, or D) are shown throughout the guideline for clinical notes and statements. For 
example, a clinical note or statement with a quality of evidence grade of “B” is shown as “(Evidence Grade: B)”.   
Evidence-Based Action Statements will be highlighted in an “Action” box, with the quality of evidence, level of 
confidence, and clinical recommendation grading information listed. For example:
EVIDENCE-BASED ACTION STATEMENT: Parents/caregivers and children should be educated about 
potential risks for eye injuries at home, at school, and during sports and recreational activities and advised 
about safety precautions to decrease the risk of ocular injury.193,199 Prevention of eye injuries in children should 
focus on the use of protective eyewear, parental supervision, and on education about both the risks of eye 
injury and the benefits of protective eyewear.194
Evidence Quality: Grade B: Retrospective cohort studies
Level of Confidence: Medium
Clinical Recommendation Strength: Strong Recommendation. This recommendation should be followed 
unless clear and compelling rationale for an alternative approach is present.
Evidence Statements: It is important to discuss eye safety issues with children/ parents/caregivers.193 
(Evidence Grade: B),199 (Evidence Grade: B)
Prevention strategies should focus on the use of protective eyewear, parental supervision, and on childhood 
education about both the risks of eye injury and the utility of protective eyewear.194 (Evidence Grade: B)
Potential Benefits: Reduction in eye injuries in 
children
Potential Risks/Harms: None
Benefit and Harm Assessment:  Benefits significantly outweigh harms
Potential Costs: Direct cost of counseling as part of a pediatric eye and vision examination
Value Judgments: None 
Role of Patient Preferences: None
Intentional Vagueness: Specific type/form of counseling is not stated, as it is patient specific
Gaps in Evidence: None identified
The Action Statement profile provides additional information related to the development and implementation of the 
clinical recommendation. The following is an explanation of the categories listed in the profile:
Evidence Quality – The quality of evidence grade (A, B, C, or D) or the aggregate quality of evidence grade (if 
multiple studies were available for review) and the type/method of research study or studies reviewed.
Level of Confidence – The consistency of the evidence and the extent to which it can be trusted specified as 
high, medium, or low.
Clinical Recommendation Strength – The grade (Strong Recommendation, Recommendation, or Option) 
assigned to the implementation of the clinical recommendation made in the Action Statement. 
Evidence Statements – The clinical statements derived from research studies reviewed that support the Action 
Statement.




Potential Benefits – Favorable changes which would likely occur if the Action Statement was followed.
Potential Risks/Harms – Adverse effects or unfavorable outcomes that may occur if the Action Statement was 
followed.
Benefit and Harm Assessment – A comparison of the relationship of benefits to harms specified as “benefits 
significantly outweigh harms” (or vice versa) or a “balance of benefits and harms.”
Potential Costs – Direct and indirect costs refer to the costs of the procedure, test, or medication; time spent 
counseling the patient; administrative time; parent/caregiver time off from work, etc.
Value Judgments – Determinations made by the Guideline Development Group in the development of the 
Action Statement relating to guiding principles, ethical considerations, or other priorities. 
Role of Patient Preference – The role the patient has in shared decision making regarding implementation of 
the Action Statement specified as large, moderate, small, or none.
Intentional Vagueness – Specific aspects of the Action Statement that are left vague due to factors such as the 
role of clinical judgment, patient variability, concerns over setting legal precedent, etc.
Gaps in Evidence – Areas identified during searches and evaluations of the research that show gaps in available 
evidence.
Consensus-Based Action Statements, based on consensus by the Guideline Development Reading Group, are 
also highlighted in an “Action” box, but without any quality of evidence or strength of clinical recommendation grading 
information listed. For example:
CONSENSUS-BASED ACTION STATEMENT: At the conclusion of a comprehensive pediatric eye and vision 
examination, the diagnosis should be explained to the patient/parent/caregiver and related to the patient’s 
symptoms, and treatment plans and prognosis discussed.
Evidence Quality: There is a lack of published research to support or refute the use of this recommendation.
Benefit and Harm Assessment: Implementation of this recommendation is likely to increase patient/
parent/caregiver understanding of any diagnosed eye or vision problems and improve compliance with any 
recommended treatment. The benefits of this recommendation were established by expert consensus opinion.
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I. INTRODUCTION
Eye and vision problems in children are a significant 
public health concern. An estimated one in five 
preschool children have vision problems.2-8 In the United 
States, about one in four school-age children wear 
corrective lenses.9 Since eye and vision problems can 
become worse over time, early diagnosis and treatment 
are essential to optimize children’s eye health and vision 
and to prevent future vision loss. 
Eye and vision disorders can lead to problems in a child’s 
normal development,10,11 school performance,12-16 social 
interactions,17 and self-esteem.17-19 Vision disorders that 
occur in childhood may manifest as problems well into 
adulthood, affecting an individual’s level of education, 
employment opportunities, and social interactions.20
Early recognition of visual disorders is especially 
important in children with developmental and intellectual 
disabilities.21,22 Children with disabilities are reported to 
have significantly more eye and vision problems (e.g., 
strabismus, refractive errors, and nystagmus) than 
children without these disabilities.22-27 The increasing 
severity of the disability may be related to a higher 
prevalence of vision problems.
This Evidence-Based Clinical Practice Guideline for the 
Comprehensive Pediatric Eye and Vision Examination 
describes procedures for evaluation of the eye health 
and vision status of infants and children. It contains 
recommendations for timely diagnosis and, when 
necessary, referral for consultation with, or treatment 
by, another health care provider. Other guidelines 
developed to address treatment of specific eye and 
vision conditions can be found at AOA Clinical Practice 
Guidelines web page.
The recommendations in this guideline were developed 
to assist doctors of optometry and ophthalmologists 
involved in providing eye and vision examinations for 
infants and children. Others who assist in providing 
coordinated patient care for specific services, as well as 
patients, parents, and caregivers, may also gain insight 
from this document.
A. GUIDELINE OBJECTIVES
This Guideline can help achieve the following objectives:
• Recommend an optimal timetable for comprehensive 
eye and vision examinations for infants and children 
(newborn through 18 years of age)
• Suggest appropriate procedures to effectively 
examine the eye health, vision status, and ocular 
manifestations of systemic disease of infants and 
children 
• Reduce the risks and adverse effects of eye and 
vision problems in infants and children through 
prevention, education, early diagnosis, treatment, 
and management
• Inform and educate patients, parents/caregivers, and 
other health care providers about the importance of 
eye health and good vision, and the need for and 
frequency of pediatric eye and vision examinations. 
II. BACKGROUND
A. VISUAL DEVELOPMENT
Development of the visual system begins prenatally and 
continues after birth.28 Basic visual functions develop 
rapidly during the first year of life. By 6 months of age, 
vision has become the dominant sense and forms the 
basis for perceptual, cognitive, and social development;29 
however, maturation of the visual system continues for 
several years. From birth to about 6 years of age, the 
visual system is susceptible to vision conditions that 
cause either blurred visual input or abnormal binocular 
interaction such as interference from amblyogenic 
bilateral refractive error, amblyogenic anisometropia, 
constant unilateral strabismus, congenital cataracts, 
hemangioma, corneal scarring, and any other condition 
that obstructs vision. This interference can lead to 
amblyopia, which, if left untreated, can cause serious 
vision loss. 
Objective testing (visual evoked response) demonstrates 
that the visual cortex is capable of achieving 20/20 
visual acuity by 6 months of age;30 however, the ability 
of a child to respond to subjective visual acuity tests is 
influenced by verbal and cognitive development. For 




some children, it may not be possible to elicit 20/20 
visual acuity until after 5 years of age; therefore, it is 
critical to select age appropriate tests. Stereopsis first 
appears at 3 to 4 months of age and continues to 
develop through the first two years of life.31, 32 Mature 
accommodative behavior is present at 5 to 24 months of 
age.33 Development of accommodative facility, vergence 
ability, and eye movements continues in the preschool 
and school-age years.34-37 
B. EPIDEMIOLOGY OF EYE AND VISION 
DISORDERS IN CHILDREN
There are many visual conditions and ocular or systemic 
diseases, which may occur in childhood that can 
affect visual development. Eye and vision disorders 
experienced by infants and children may include:
• Refractive errors
Refractive errors (hyperopia, myopia, astigmatism, 
and anisometropia) are the most common causes of 
correctable reduced vision in children.38, 39 Estimates of 
refractive errors in children 6 months to 72 months (6 
years) of age are shown in Table 1.
Hyperopia has a high prevalence among young children 
up to 5 years old, with over 20% estimated to have 
≥2.00 diopters (D).2,3 Hyperopia (≥2.00D) is found to be a 
significant risk factor for the development of strabismus40 
and amblyopia41 up to 5 years of age.
Myopia generally develops in children during their early 
school years and increases in magnitude, as they get 
older. The age at onset typically ranges from 7 to 16 
years. In the Collaborative Longitudinal Evaluation of 
Ethnicity and Refractive Error Study (CLEERE), one in six 
children ages 5 to 16 (Asian, Hispanic, African American, 
Native American and White) developed myopia during 
their school-age years. More than 75% of the new cases 
of myopia occurred between the ages of 9 and 13.42
Among school-age children, the prevalence of myopia 
has been increasing in recent years and developing at 
a younger age.42,43 The National Health and Nutrition 
Examination Survey results for 12 to 17 year olds show 
the prevalence of myopia increased from 24% in 1971-
1972 to 33.9% in 1999-200444 and it continues to rise. 
High levels of myopia can contribute to the development 
of lattice degeneration, retinal holes, tears, or 
detachment, cataracts, glaucoma, and myopic macular 
degeneration.45,46 
Astigmatism up to 2.00D is common in children under 
3 years of age. Studies show that 30 to 50% of infants 
less than 12 months of age have astigmatism (≥1.00D), 
which declines over the first few years of life, and 
becomes stable by approximately 2 1/2 to 3 years of 
age.47, 48 
Anisometropia of 1.00D or more is considered 
clinically significant. There is a low prevalence (4%) of 
anisometropia before 6 years of age;49 however, it has 
been shown to increase to nearly 6% at 12 to 15 years 
of age. Infantile anisometropia can be transient and 
may decrease; however, severe anisometropia (≥3.00D) 
may persist and is likely to lead to the development of 
amblyopia during the preschool years.50, 51
Table 1: Prevalence of Refractive Errors in Children 












1.2% 3.7% 6.6% 4.0%
≥1.00D SE 0.7% 5.5%
Hyperopia
≥2.00D SE 25.7% 26.9% 20.8% 13.5%









≥1.00D SE 4.3% 4.2%
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Source: Multi-Ethnic Pediatric Eye Disease 
Study 2-4,49 and the Baltimore Pediatric Eye Disease 
Study 5 
(Note: The ethnicity of children reported in Tables 1, 2, 3 
and 4 is based on the categorization used in the studies 
cited.)
Table 2: Prevalence of Refractive Errors in Children 










≥0.75D in each 
principal meridian
4.4% 13.2% 6.6% 18.5%
Hyperopia
≥1.25D in each 
principal meridian





26.4% 36.9% 20.8% 33.6%
Source: Collaborative Longitudinal Evaluation of 
Ethnicity and Refractive Error Study 52 
In the school-based CLEERE study of children 5 to 17 
years of age, overall 9.2% of the children were myopic, 
12.8% were hyperopic, and 28.4% had astigmatism 
(Table 2).
Click to view the (AOA Clinical Practice Guidelines web 
page)
• Amblyopia
Amblyopia is the leading cause of monocular vision loss 
in children. It is generally attributable to strabismus, 
anisometropia, combined strabismus and anisometropia, 
or form deprivation (e.g., media opacity). Unilateral 
amblyopia is commonly associated with constant 
unilateral strabismus and/or amblyogenic anisometropia, 
while bilateral amblyopia usually results from high bilateral 
refractive error 53 or bilateral form deprivation.
Although amblyopia is a treatable condition in both 
children and adults,54 the end result is better when 
diagnosed and treated early.55-60 The prevalence of 
amblyopia in the general population is believed to be 
between 2% and 2.5%.61 Estimates of the prevalence of 
amblyopia in young children in an urban population are 
shown in Table 3. 
Click to view the (AOA Clinical Practice Guidelines web 
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• Strabismus
The estimated prevalence of strabismus in the general 
population varies from 2.5% to 4.6% based on various 
studies.62 The prevalence of strabismus in young children 
in an urban population is shown in Table 3. 
Although strabismus can develop at any age, it usually 
develops during childhood. Infantile esotropia has 
an onset prior to 6 months of age; accommodative 
esotropia typically has an onset between 2 to 3 years 
of age, but can develop before 6 months of age. Young 
children with constant unilateral strabismus often develop 
amblyopia and impaired stereopsis. Early identification 
and treatment of children with strabismus may prevent 
amblyopia and preserve stereopsis.
Table 3: Prevalence of Amblyopia and Strabismus 








Amblyopia 1.8% 2.6% 0.8% - 1.5% 1.8%
Strabismus 3.2% - 3.3% 2.4% 2.1% - 2.5% 3.6%
Source: Multi-Ethnic Pediatric Eye Disease Study 6, 8 
and the Baltimore Pediatric Eye Disease Study 7
Click to view the (AOA Clinical Practice Guidelines web 
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• Non-strabismic binocular vision problems and 
accommodative disorders
Other than refractive errors, the most prevalent 
vision conditions in children fall into the category of 
accommodative and binocular vision anomalies, as 




reported in a large-scale prospective study of the 
prevalence of vision disorders and ocular disease in a 
clinical population of children between the ages of 6 
months and 18 years.63 
Oculomotor conditions
Oculomotor conditions include a variety of eye 
movement disorders, which can affect saccadic, 
fixation, and vergence eye movements. 
Convergence insufficiency (CI) is a binocular vision 
disorder that affects up to 8.3% of school-age 
children64 and is associated with symptoms such 
as eyestrain, headaches, blurred vision, diplopia, 
sleepiness, difficulty concentrating, movement 
of print while reading, loss of place, and loss of 
comprehension after short periods of reading.65-67 
The Convergence Insufficiency and Reading Study 
Group investigators found that 13% of fifth and 
sixth grade children (definite and high suspect) 
had clinically significant CI (insufficient fusional 
convergence, receded nearpoint of convergence, 
and/or exophoria at near ≥4 prism diopters at far).68 
Convergence excess (CE) has been reported 
to occur in 7.1% of children in one clinical 
pediatric population.63 It may be due to a high 
accommodative convergence/accommodation 
(AC/A) ratio. Symptoms can include blurred vision, 
diplopia, headaches, and difficulty concentrating on 
near tasks. 
Accommodative disorders
Children with accommodative dysfunctions may 
have difficulty focusing on near objects, maintaining 
focus for long periods, or easily changing focus 
from near to far and back again. Studies in clinic 
populations have been conducted to determine 
the prevalence of accommodative dysfunction. 
A study of over 2,000 children found that 5% of 
children between the ages of 6 and 18 years had 
accommodative disorders.63 
Click to view the (AOA Clinical Practice Guidelines 
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• Color vision deficiency
Children with color vision deficiency, either inherited or 
acquired, may have difficulty precisely matching colors 
or discriminating fine color differences. Inherited (X 
chromosome) color vision deficiency is estimated to 
occur in nearly 8% of white males and less than 0.4% of 
white females, with lower prevalence in other ethnicities 69 
(Table 4). The severity of color vision deficiency can 
range from mild to severe. The most common form of 
color vision deficiency is red-green. Less common is 
blue-yellow color vision deficiency. 
Table 4: Prevalence of Inherited Color Vision 
Deficiency in Children 61 Months (5 years) to 72 









Boys 7.8% 2.9% 2.1% 3.5%
Girls <0.4% <0.4% <0.4% <0.4%
Source: Multi-Ethnic Pediatric Eye Disease Study 69
• Ocular Diseases 
Ocular inflammatory disease
Ocular inflammation in children involves an array of 
conditions, including but not limited to conjunctivitis, 
keratitis, scleritis, and uveitis. It may occur due 
to infection, trauma, malignancy, or autoimmune 
response. Inflammations can range from benign and 
self-limiting to chronic and sight-threatening.70, 71
Systemic autoimmune diseases in children can have 
ocular manifestations that are vision-threatening. 
Juvenile idiopathic arthritis is associated with the 
development of chronic anterior uveitis. Other 
diseases with ocular inflammatory manifestations 
include sarcoidosis, juvenile rheumatoid arthritis, 
Behçet’s disease, and Sjögren’s syndrome.71, 72
Ocular conditions of prematurity 
Children born prematurely are at risk for the 
development of severe visual impairment and 
blindness. Preterm infants have higher rates of 
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amblyopia, strabismus, optic atrophy, and refractive 
errors.73-76
Sixty percent of infants born at 28 to 31 weeks have 
been reported to develop retinopathy of prematurity 
(ROP) and over 80% of infants born before 28 
weeks developed ROP.77 ROP is also common in 
children with birth weight of less than 1,251 grams 
(g). Oxygenation of infants in the hours and days 
after birth may also be a contributing factor.78 The 
frequency and severity of ROP is inversely related to 
gestational age and birth weight of the baby.79 The 
incidence of ROP is 47% in infants with birth weights 
between 1,000 and 1,251 g and 81.6% in infants 
weighing <1,000 g at birth.77 
Cataract 
Childhood cataracts can be classified as congenital 
or developmental. They may be idiopathic, due 
to infection (e.g., rubella), genetics (e.g., Down 
syndrome), or the result of secondary causes such 
as trauma or metabolic etiology. The prevalence of 
visually significant congenital cataracts is estimated 
to be three to four infants per 10,000 live births.80 
If not treated early, visually significant congenital 
cataracts may cause vision impairment.
Glaucoma
Childhood glaucoma is an uncommon disease 
characterized by increased intraocular pressure 
leading to optic neuropathy and visual field changes, 
and is often associated with significant vision loss.81 
It may be inherited or associated with other eye 
disorders.
Glaucoma in children may be classified as congenital 
(present at birth), infantile (occurring between 1 to 
2 years of age), or juvenile (developing after age 3). 
Most cases develop during the first year of life. A 
review of records of pediatric patients seen in one 
county in the United States over a 40-year period 
found an incidence of glaucoma of 2.29 per 100,000 
persons younger than 20 years of age.81
Retinitis pigmentosa
Retinitis pigmentosa (RP) is a group of hereditary 
retinal diseases characterized by progressive loss 
of peripheral vision and the development of night 
blindness. RP is caused by the degeneration of 
photoreceptor cells resulting in severe damage to 
the retina. While RP is usually limited to the eye, it 
may also occur as part of a syndrome (e.g., Usher 
syndrome, Bardet-Biedl syndrome).82 
Retinitis pigmentosa is the most frequent cause 
of inherited visual impairment.82 It is estimated to 
affect 1 in 3,000 to 1 in 4,000 people in the United 
States.83 
Retinoblastoma 
Retinoblastoma, a cancer of the retina, usually 
affects children under age 5. The most common 
signs of retinoblastoma are leukocoria (white 
pupillary reflex) and strabismus. Retinoblastoma 
accounts for approximately 11% of cancers 
occurring in the first year of life, with 95% diagnosed 
before 5 years of age.84 It is the most common 
intraocular cancer of childhood and affects 
approximately 300 children in the United States each 
year. More than 90% of children with retinoblastoma 
could be treated with early diagnosis;85 however, 
significant disparities exist in the care and outcomes 
of children with retinoblastoma.86 
Retinoblastoma is associated with a mutation 
of the RB1 gene. The tumor may be unilateral 
or bilateral and can be inherited. Prognosis for 
survival, saving the eye, and preservation of vision 
are largely dependent on the stage of disease at 
presentation. Early diagnosis, multidisciplinary 
treatment, and genetic counseling are all priorities in 
the management of this tumor.87 
Diabetic retinopathy
Diabetes is the third most common chronic disease 
among children and a leading cause of vision 
impairment among young adults. Type 1 diabetes 
mellitus has historically been the most common 




type in children, affecting approximately 2 per 1,000 
school-age children in the United States; however, 
Type 2 diabetes mellitus now accounts for about 
45% of new cases of the disease.88, 89 
Diabetic retinal disease, primarily manifesting as 
diabetic retinopathy (DR) and/or diabetic macular 
edema, is the most common microvascular 
complication of diabetes. Among pediatric patients, 
the average duration of diabetes before the 
development of DR is 5.7 to 9.1 years; however, the 
risk for developing DR is greater in patients who are 
diagnosed with diabetes during or after puberty.88
Click to view the (AOA Clinical Practice Guidelines 
web page)
Optic nerve hypoplasia 
Optic nerve hypoplasia is one of the most prevalent 
causes of visual impairment among young children. 
Although the specific prevalence is unknown, 
the Babies Count Registry reported optic nerve 
hypoplasia as the third most prevalent cause of 
vision impairment in children age 3 years or younger 
in the United States.90
The exact cause of optic nerve hypoplasia in not 
known, but it may be associated with prenatal 
exposure to alcohol, smoking, recreational drugs, 
antidepressants and anticonvulsants, and with 
prenatal complications including gestational 
diabetes, toxemia, viral infection, and maternal 
anemia. Seventy percent of the cases identified have 
no known risk factors. More recent studies have 
indicated the mother’s young age (≤ 20 years) and 
primiparity (that is, the affected child is the mother’s 
first child, regardless of the mother’s age) are the 
predominant characteristics in the background of 
children with optic nerve hypoplasia.91
Optic nerve hypoplasia was believed to occur 
either as an isolated anomaly or accompanying 
the syndrome of septo-optic dysplasia or de 
Morsier syndrome 92 that includes midline brain 
malformations and hypopituitarism. Evidence now 
suggests that optic nerve hypoplasia infrequently 
occurs in isolation and is more appropriately 
designated as the syndrome of optic nerve 
hypoplasia.93 In the syndrome, most children 
with optic nerve hypoplasia have hypothalamic 
dysfunction and/or neurodevelopmental impairment, 
such as cerebral palsy or growth problems.
Cortical (cerebral) visual impairment 
Cortical visual impairment (CVI) is defined as a 
reduction or complete loss of visual acuity and 
optokinetic nystagmus due to injury to the visual 
cortex, with preservation of pupillary response, 
normal eye motility, and normal retina.94 In addition 
to cortical visual impairment, the term cerebral visual 
impairment is also used to describe not only visual 
impairment associated with the visual cortex, but 
also regions outside the cortex that can affect other 
visual pathway structures.95 
In children experiencing perinatal or postnatal 
hypoxia/ischemia, CVI, retinopathy of prematurity, 
and optic nerve hypoplasia were commonly identified 
conditions. Of the three, CVI was the most prevalent 
visual condition identified and was often the last to 
be diagnosed.90 
Vision loss associated with brain damage is reported 
to be a significant cause of visual impairment 
in young children. Identification of children with 
suspected CVI requires neuroimaging to ascertain 
the extent of the injury to specific regions in the 
brain. Failure to do so will underestimate the level of 
visual dysfunction and systemic disability.96 
C. ACCESS TO CARE
Although comprehensive pediatric eye and vision 
examinations are essential for timely diagnosis and 
treatment of eye disease and maintenance of good 
vision, many children do not receive comprehensive 
eye care. An estimated one in five preschool children 
and one in four school-age children in the United States 
has a vision problem; however, the Centers for Disease 
Control and Prevention report that less than 15% of 
preschoolers receive an eye examination by an eye care 
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professional and less than 22% receive some type of 
vision screening.97
A factor that may limit access to comprehensive eye and 
vision examinations and treatment services is the false 
sense of security that school screenings mistakenly give 
to parents (false negative results). Other factors that limit 
access include the absence of signs, symptoms, or a 
family history of eye and vision problems,98 or the inability 
of parents/caregivers to afford needed services due to 
lack of insurance coverage or limited family income.99 
Limited access may now be partially resolved because 
comprehensive eye and vision examinations have 
received increased attention from the Affordable Care 
Act and other insurance programs reviewing essential 
health benefits necessary for children.
D. COST OF EYE AND VISION DISORDERS 
IN CHILDREN
Eye and vision disorders can impose a significant burden 
on patients, parents, and the public. The total economic 
cost of vision loss and eye disorders among children 
younger than 18 years of age in 2012 was estimated 
to be $5.9 billion.100 This includes the direct medical 
costs for eye examinations, eyeglasses, and low vision 
aids. Also, the debilitating nature of vision loss results in 
major indirect and nonmedical costs including special 
education services, federal assistance programs, and 
decreased quality of life.
The above estimate does not include the costs of 
educational services for children with undiagnosed 
and untreated vision conditions. Learning-related 
vision problems have been reported to be significant 
contributors to reading difficulties and ultimately to the 
need for special education services.14, 15, 65, 101, 102 Vision 
problems can increase educational costs in the form of 
Individualized Education Programs (IEPs) and special 
education services, which would otherwise not be 
necessary, if the vision problems were treated. A study 
of students (ages 6-16) with IEPs found that they have 
high rates of undiagnosed and untreated vision problems 
affecting reading speed and comprehension.103
In addition to the current costs of care, future costs for 
undiagnosed and untreated vision problems may include 
the loss of a child’s full potential, and limitations on his 
or her occupational choices and future earnings. The 
cost of treating any visual impairment later in life could 
potentially be more expensive than treatment of the initial 
problem.
E. EARLY DETECTION AND PREVENTION 
OF EYE AND VISION DISORDERS
Many vision conditions are asymptomatic or not readily 
recognized, and will not prompt a patient, caregiver, 
or parent to seek a comprehensive eye and vision 
examination.104 Undiagnosed or uncorrected refractive 
errors and other visual disorders in children can lead 
to developmental, academic, and social challenges 
and in some cases permanent vision loss, which has 
lifelong complications.105 In the preschool population, the 
concern is for early diagnosis and treatment of significant 
refractive error, amblyopia, strabismus, and ocular 
disease. For the school-age population, the concern 
is the negative impact that untreated vision disorders 
(accommodation, binocular vision, ocular motility, 
and vision information processing) have on academic 
performance.
A comprehensive eye examination by a doctor of 
optometry or ophthalmologist is the reference standard 
of eye care.105 Not all children receive professional eye 
examinations for various reasons including education 
and language barriers, health literacy, cost, geographic 
access, immigration status, and transportation 
challenges.106
The role of vision screenings in addressing the current 
gaps in children’s eye care remains unclear. The U.S. 
Preventive Services Task Force (USPSTF) has concluded 
that the current evidence is insufficient to assess the 
balance of benefits and harms of vision screening 
for children 3 years of age and younger.107 While the 
USPSTF concluded with moderate certainty that vision 
screening for children 3 to 5 years of age has moderate 
net benefit compared with no screening, they did not 
compare the benefit of screening to a comprehensive 
eye examination.108
Vision screening procedures lack the evidence needed, 
with proven high sensitivity and specificity, for identifying 




the targeted vision problems present in the population 
of children being screened.104,109 The sensitivity of a 
wide variety of screening techniques was evaluated 
by the Vision in Preschoolers (VIP) study, which unlike 
standard screenings used licensed eye doctors who had 
completed VIP study specific training and certification.104 
In the study, the sensitivity of 11 vision screening 
techniques used for detecting clinically significant vision 
problems in children 3 to 5 years of age varied from 16% 
to 64%, with specificities ranging from 62% to 98%. 
These tests were compared again with a specificity of 
94%, and the sensitivity dropped even further.109 When 
these same tests were performed by trained nurses or 
lay screeners (except for non-cycloplegic retinoscopy, 
which was deemed too technically challenging), the 
sensitivity was similar or lower.110 Even with the use of 
trained examiners, these vision screening techniques 
were unable to provide high levels of both sensitivity and 
specificity for detecting many vision problems in children. 
Currently, widespread application of vision screenings 
do not utilize licensed eye care professionals or the 
techniques found to be most sensitive.
When Snellen visual acuity alone was used as a 
screening tool, it was 100% specific for identifying 
reduced acuity, but missed 75.5% of the children found 
to have binocular and oculomotor vision problems when 
given a complete visual examination.111 Additionally, a 
study of 1,992 school-age children found that 41% of 
children who failed the State University of New York 
screening battery would not have been identified if the 
screening was based on visual acuity alone.112 
Many children who fail a screening do not receive the 
necessary treatment of their conditions. A study of public 
school children reported only 38.7% who failed the vision 
screening received follow-up care after screenings.113 
Due to a lack of follow-through, screenings alone may 
not lead to the earlier diagnosis and treatment of eye 
and vision problems. While screenings may identify some 
children at risk for vision problems, a comprehensive 
eye exam is necessary for definitive diagnosis and 
appropriate treatment.114
III. CARE PROCESS
A. COMPREHENSIVE PEDIATRIC EYE AND 
VISION EXAMINATION
The comprehensive pediatric eye and vision examination 
provides the means to evaluate the structure, function, 
and health of the eyes and visual system. It is preferable 
in most cases for the parent/caregiver to accompany 
the child into the examination room. The in-person 
interaction between patient/parent/caregiver and doctor 
is a dynamic process. It involves collecting subjective 
data from the patient/parent/caregiver and obtaining 
objective data by observation, examination, and testing. 
During the examination, information is obtained to 
explain symptoms reported by the patient and/or parent/
caregiver and diagnose their cause. It also provides 
the means to identify the presence of other ocular or 
systemic conditions that may exist with or without 
symptoms. (See Appendix Figure 1.)
The goals of the comprehensive pediatric eye and vision 
examination are to: 
• Evaluate the refractive, binocular, and 
accommodative status of the eyes and visual 
system, taking into account special vision demands 
and needs
• Assess ocular health and related systemic health 
conditions 
• Establish a diagnosis (or diagnoses)
• Formulate a treatment and management plan 
• Counsel and educate the patient/parent/caregiver 
regarding visual, ocular, and related systemic 
health care status, including recommendations for 
prevention, treatment, management, and future care. 
1. General Considerations
Since the capabilities and needs of children vary 
significantly by age, the potential components of the 
comprehensive pediatric eye and vision examination 
have been divided into three age groups. This 
subdivision of the pediatric population is based on the 
developmental changes that occur from birth through 
childhood. The following age groups were also chosen 
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to be compatible with those used by other medical and 
governmental groups involved with children’s health. 
Because an individual child’s development can vary 
significantly from expected age norms, it is important 
not to rely solely upon chronological age when choosing 
testing procedures. Appropriate test procedures need to 
be based on the child’s developmental age and specific 
capability. 
a. Infants and Toddlers (newborn through 2 years of 
age)
Children in this age group may perform best if the 
examination is early in the morning or after an infant’s 
nap. Age-appropriate examination strategies should be 
used. It is necessary to rely on objective examination 
procedures and to perform tests more rapidly than with 
older children. 
b. Preschool Children (3 years through 5 years of 
age)
At about 3 years of age, children have achieved 
adequate receptive and expressive language skills 
to begin to cooperate for some of the traditional eye 
and vision tests; however, testing modifications are 
often needed to gather useful information. Beginning 
the examination with procedures that appear less 
threatening may help to put the child at ease. The use of 
subjective tests requiring verbal interaction may need to 
be modified.
c. School-age Children (6 through 18 years of age)
Most of the examination procedures used on 
adults apply to this age group; however, for some 
patients, modifications should be made to improve 
understanding and cooperation. Utilization of tests 
designed for younger age groups may be appropriate. 
Tests of accommodation, oculomotor skills, and 
binocular function should be included as part of the 
comprehensive examination.
2. Examination Procedures**
The examination procedures described are not intended 
to be all-inclusive. Professional judgment and individual 
patient symptoms and findings may significantly influence 
the nature and course of the examination. It is important 
to remain alert for new and emerging technologies, 
instruments, and procedures and incorporate them into 
the clinical examination, as appropriate.
CONSENSUS-BASED ACTION STATEMENT: 
A comprehensive pediatric eye and vision 
examination should include, but is not limited to:
• Review of the nature and history of the presenting 
problem, patient and family eye and medical 
histories, including visual, ocular, general health, 
leisure and sports activities, and developmental 
and school performance history of the child 
• Measurement of visual acuity
• Determination of refractive status
• Assessment of binocular vision, ocular motility, and 
accommodation
• Evaluation of color vision (baseline or periodic, if 
needed, for qualification purposes or if disease 
related)
• Assessment of ocular and systemic health, 
including evaluation of pupillary responses, 
anterior and posterior segment, peripheral retina, 
evaluation/measurement of intraocular pressure, 
and visual field testing. 
Refer to section III. Care Process, A. 9 for a listing of 
potential benefits and harms of testing.
Evidence Quality: There is a lack of published 
research to support or refute the use of all of 
the tests and/or assessments included in this 
recommendation.
Benefit and Harm Assessment: Implementation 
of this recommendation is likely to result in the 
enhanced ability to diagnose any eye or vision 
problems in infants and children. The benefits of 
this recommendation were established by expert 
consensus opinion.
** See Appendix Tables 1, 2, and 3 for a listing of 
specific tests by age group.





The patient history is an initial and ongoing component 
of the examination. The objective is to obtain specific 
information about the patient and/or parent’s/caregiver’s 
perception of the child’s eye and vision status and 
important background information on related medical 
issues. It helps to identify and assess problems, and it 
provides an opportunity to become acquainted with the 
patient and/or his/her parents or caregivers, establishing 
a relationship of confidence and trust. 
The collection of demographic data generally precedes 
the taking of the patient history. Having the parent 
or caregiver fill out a questionnaire may facilitate 
obtaining the patient and family history, if known. Major 
components of the patient history include, but are not 
limited to:
• Nature and history of the presenting problem, 
including chief complaint
• Visual and ocular history
• General health history, including prenatal, 
perinatal and postnatal history, and review of 
systems, surgical and/or head or ocular trauma 
history, and any vision or ocular treatment
• Medication reconciliation, including prescription 
and nonprescription drugs (e.g., over the 
counter medications, supplements, herbal 
remedies) and documentation of medication 
allergies
• Family ocular and medical history
• Clinical note: It is recommended that the 
patient history should also include the refractive 
status of both parents,115, 116 (Evidence Grade: 
B) because it is a possible risk factor for the 
progression of myopia in school-age children.
• Developmental history of the child
• School performance history of school-age 
children
• Time spent outdoors, on sports activities, and 
on near work and screen viewing
• Names of, and contact information for, the 
patient’s other health care providers.
4. Testing 
4.1 Testing of Infants and Toddlers (newborn 
through 2 years of age)
 a. Visual Acuity
Estimation of visual acuity in an infant or toddler can help 
to confirm or reject certain hypotheses about the level of 
visual system development, including binocularity, and 
provide direction for the remainder of the eye and vision 
examination. Assessment of visual acuity for infants and 
toddlers may include these procedures:
• Preferential looking visual acuity 
Preferential looking methods are useful for the 
assessment of visual acuity in infants and toddlers. 
Grating acuity targets (e.g., Teller acuity cards) and 
vanishing optotypes (e.g., Cardiff acuity test) can 
provide estimates of resolution visual acuity.117 
• Fixation preference test 
Fixation preference testing results need to be 
interpreted in the context of all other available 
information (e.g., degree and type of anisometropia, 
frequency and type of strabismus). Results of 
fixation preference testing may be unreliable for 
diagnosing amblyopia,118, 119 particularly secondary 
to anisometropia; therefore, monocular visual acuity 
measurements should be obtained, if possible.120 
• Visual evoked potential
Electrodiagnostic testing, such as visual evoked 
potentials, is an objective method that can be used 
to provide an estimate of visual acuity in infants.121 
b. Refraction
Objective measures of refraction with a lens bar or loose 
lenses should be used in this age group because of the 
short attention span and poor fixation of infants. The 
refractive error measurement should be analyzed with 
other testing data obtained during the examination. This 
: Comprehensive Pediatric Eye & Vision Examination
Published by The Athenaeum, 2020
20
information is used to determine if, and in what amount, 
an optical correction is needed. Procedures may include:
• Cycloplegic retinoscopy 
When performing cycloplegic retinoscopy in an infant 
or toddler, the appropriate cycloplegic agent should 
be selected carefully.122 The lowest concentration 
of drug that yields the desired cycloplegia should 
be used. A concentration of 0.5% cyclopentolate 
hydrochloride can be used in most infants under 
12 months of age and a 1% concentration for 
older children.123 Combination drops (0.2% 
cyclopentolate hydrochloride and 1% phenylephrine) 
are also available for use with infants. The potential 
for systemic absorption may be reduced with 
nasolacrimal occlusion. The cycloplegic of choice 
is cyclopentolate hydrochloride; however, when it 
is not available or is contraindicated, tropicamide 
1% has also been shown to be effective for the 
measurement of refractive error in non-strabismic 
infants.124 
Spray administration of cyclopentolate to the open 
or closed eyes of young children is an acceptable 
alternative, if necessary, to using eye drops and is 
often better tolerated and less distressing than other 
methods of drug administration;125-128 however, the 
use of cyclopentolate spray in children with dark 
irides may not achieve adequate cycloplegia.129 
Spray caps are available for use on bottles of 
cyclopentolate, eliminating the need to have the 
spray compounded by a pharmacy.
• Non-cycloplegic retinoscopy 
Non-cycloplegic retinoscopy performed at near is 
an objective means of estimating refractive error 
in infants and toddlers,130 but should be used with 
caution as a substitute for cycloplegic retinoscopy.131 
It may be useful when a child/parent is extremely 
anxious about instillation of cycloplegic agents, 
or the child has had, or is at risk for, an adverse 
reaction to cycloplegic agents.132 
Video refraction without cycloplegia can also be 
used to detect infants with significant ametropia, 
particularly hyperopia or other accommodative 
problems.133
c. Binocular Vision and Ocular Motility
Depending on the patient’s age, level of cooperation, 
and visual signs and symptoms, appropriate tests 
of binocular vision and ocular motility should be 
incorporated into the examination. Testing in this age 
group may include:
• Ocular alignment assessment 
The unilateral cover test at distance and near can 
generally be used with very young children. If cover 
test results are unreliable because of the child’s 
resistance to testing, use of the Hirschberg test 
may be successful. Prisms can be used with the 
Hirschberg test to align the corneal reflex (Krimsky 
test) and estimate the magnitude of any deviation.
• Brückner test
If cover test results are equivocal, particularly in 
young or uncooperative patients, the Brückner test 
may be helpful in detecting strabismus, including 
small angle strabismus. It may also be useful in 
the clinical evaluation of anisometropia in infants 
and young children.134 Increasing the examination 
distance from one meter to four meters can improve 
its sensitivity for detecting anisometropia.135 
• Stereopsis
Testing of stereopsis, after 6 months of age, can 
provide a sensitive measure of visual development in 
infants.136 In this population, tests like the Preschool 
Assessment of Stereopsis with a Smile (PASS) 3, 
which uses a preferential looking paradigm, should 
be used.
• Near point of convergence (NPC)
Assessment of convergence ability may be 
determined objectively in infants using a penlight or 
other interesting targets, which include sounds or 
blinking lights.




• Ocular motility assessment 
Versions and eye tracking abilities may be assessed 
using a penlight, small toy, or other object.
4.2 Testing of Preschool Children (3 through 5 years 
of age)
a. Visual Acuity
The accurate measurement of visual acuity in children 
allows for the early detection of amblyopia and 
significant/high refractive errors. While some children in 
this age group may respond verbally, acuity testing may 
require the use of a matching or a forced-choice task. An 
assessment of visual acuity may include the use of:
• Symbol optotype or letter matching visual acuity 
measurement
Symbol optotype or letter optotype testing (e.g., Lea 
symbols) and letter matching testing (e.g., HOTV) 
can be used to measure the visual acuity of most 
children aged 3 through 5 years.137-140 
b. Refraction
A refraction should include objective and, as appropriate, 
subjective assessment of the child’s refractive status; 
however, the results of a refraction do not provide 
all the information needed to determine an optical 
prescription. The refractive error measurement should be 
analyzed with other testing data and the patient’s visual 
needs obtained during the in-person examination. This 
information is used to determine if, and in what amount, 
an optical correction is needed to provide optimal vision 
and comfort for all viewing distances. Testing in this age 
group may include:
• Static (distance) retinoscopy
Use of a lens rack or loose lenses with appropriate 
control of accommodation, rather than a phoropter, 
enables the child’s eyes to be seen and allows for 
observation if the child loses fixation. Viewing a video 
may assist in capturing a child’s attention in order to 
sustain distance fixation. 
• Cycloplegic retinoscopy
Spray administration of cyclopentolate to the open 
or closed eyes of young children is an acceptable 
alternative, if necessary, to using eye drops and is 
often better tolerated and less distressing than other 
methods of drug administration;125-128 however, the 
use of cyclopentolate spray in children with dark 
irides may not achieve adequate cyclopelgia.129 
Spray caps are available for use on bottles of 
cyclopentolate, eliminating the need to have the 
spray compounded by a pharmacy.
CONSENSUS-BASED ACTION STATEMENT: 
Cycloplegic retinoscopy is the preferred procedure 
for the first evaluation of preschoolers. It is 
necessary to quantify significant refractive error 
in the presence of visual conditions such as 
strabismus, amblyopia, and anisometropia.
Evidence Quality: There is a lack of published 
research to support or refute the use of this 
recommendation.
Benefit and Harm Assessment: Implementation 
of this recommendation is likely to enhance the 
ability to evaluate and diagnose eye and vision 
problems in preschool children. The benefits of 
this recommendation were established by expert 
consensus opinion.
• Autorefraction
The use of a hand-held autorefractor is preferable in 
this age group since it may be less intimidating than 
a table mounted instrument. 
Autorefractors can provide an objective measure 
of refractive error, but may underestimate the level 
of hyperopia and overestimate the level of myopia 
under non-cycloplegic conditions,141, 142 and their 
usefulness in testing children less than 3 years of 
age may be limited.143 
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c. Binocular Vision, Ocular Motility, and 
Accommodation
• Ocular alignment assessment (distance and 
near)
Testing should include use of the unilateral cover 
test and alternating cover test. If cover test results 
are unreliable because of the child’s resistance 
to testing, use of the Hirschberg test may be 
successful. Prisms can be used with the Hirschberg 
test to align the corneal reflex (Krimsky test) and 
estimate the magnitude of any deviation.
• Ocular motility assessment
 Examination of eye movements in this age group 
involves an assessment of comitancy. 
• Near point of convergence (NPC)
Assessment of maximum convergence ability may 
be determined objectively or subjectively.
• Stereopsis 
In the preschool population, stereopsis testing can 
provide useful information about development of 
binocular vision and eye alignment. Testability in this 
age group has been reported to be close to 90% 
using age appropriate techniques.136, 144, 145 The 
presence of global stereopsis is an indication that 
the patient is bifoveally fixating and evidence that a 
constant strabismus is less likely to be present.146, 
147 This information is valuable when the cover test 
results are equivocal and the clinician suspects a 
small angle, constant strabismus may be present. 
To accomplish this objective, a stereopsis test that 
assesses global, rather than local stereopsis, should 
be used. The PASS 3 and the Randot Preschool 
tests are examples of global stereopsis tests that 
can be used for this purpose. Stereopsis tests that 
have monocular cues (local stereopsis e.g., Titmus 
Test) may lead to false-positive results.147 
• Positive and negative fusional vergence ranges
Assessment of positive and negative fusional 
vergence ranges can be done using a step vergence 
procedure with a hand-held prism bar. 37, 148
• Accommodative testing 
Clinical note: Dynamic retinoscopy has been 
shown to be a reliable method for assessing 
accommodation in young children.149,150 (Evidence 
Grade: B)
d. Color Vision 
Children with color vision deficiency, either congenital or 
acquired, may have difficulty precisely matching colors 
or discriminating fine color differences.151 The severity 
of color vision deficiency can range from mild to severe 
depending on the cause. Most children can be reliably 
evaluated for color vision deficiency after 60 months (5 
years) of age.69 
It is helpful to know whether a color vision deficiency 
exists, because severe color vision deficiency may 
cause a child to be misidentified as learning disabled.152 
Identification of abnormal color vision prior to school 
age is also important, since part of the early educational 
process generally involves the use of color identification 
and discrimination. The presence of a color vision 
deficiency may also indicate an ocular health problem; 
therefore, color vision testing may need to be repeated, if 
an acquired color vision deficiency is suspected. 
Although effective when used with standard illuminant, 
some pseudoisochromatic plate tests only detect protan 
and deutan color vision deficiency,153 while other color 
vision tests provide the added advantage of detection 
of tritan defects and the ability to categorize defects as 
mild, moderate, or severe.154 
4.3 Testing of School-age Children (6 through 18 
years of age)
a. Visual Acuity
Visual acuity may be measured monocularly and 
binocularly, at distance and near, with and without the 
child’s most recent spectacle or contact lens correction. 




An assessment of visual acuity in children age 6 years or 
older may include:
• Snellen visual acuity 
For some children, Snellen visual acuity testing may 
need to be modified by isolating one line, or even 
one-half line of letters. If amblyopia is suspected, 
single letters with surround bars should be used. 
• Early Treatment of Diabetic Retinopathy Study 
(ETDRS) visual acuity chart
The ETDRS chart may be used to measure visual 
acuity in school-age children155 and can be especially 
useful in diagnosing and monitoring children with 
amblyopia.
b. Refraction
A refraction may include objective and subjective 
assessment of a child’s refractive status; however, the 
results of a refraction do not provide all the information 
needed to determine an optical prescription. The 
refractive error measurement should be analyzed with 
other testing data and the patient’s visual needs obtained 
during the in-person examination. This information is 
used to determine if, and in what amount, an optical 
correction is needed to provide optimal vision and 
comfort for all viewing distances.
Both objective and subjective testing for refractive error 
can generally be used in this age group. It may include:
• Static (distance) retinoscopy
Retinoscopy may be performed with a phoropter, or 
without a phoropter using a lens rack or loose lenses 
and fogging glasses.
• Cycloplegic retinoscopy
CONSENSUS-BASED ACTION STATEMENT: 
Cycloplegic retinoscopy is the preferred procedure 
for the first evaluation of school-age children. 
It is necessary to quantify significant refractive 
error in the presence of visual conditions such as 
strabismus, amblyopia, and anisometropia.
Evidence Quality: There is a lack of published 
research to support or refute the use of this 
recommendation.
Benefit and Harm Assessment: Implementation 
of this recommendation is likely to enhance the 
ability to evaluate and diagnose eye and vision 
problems in school-age children. The benefits of 
this recommendation were established by expert 
consensus opinion.
Clinical note: In school-age children, cycloplegic 
refraction results in a more positive spherical 
power measurement than that obtained 
using optical fogging techniques to relax 
accommodation.156 (Evidence Grade: B) The 
difference in spherical equivalent refractive errors 
measured in pre- and post-cycloplegic refractions 
is significant up until age 20.157 (Evidence Grade: 
B)
• Subjective refraction
Typical examination procedures used to measure 
refractive error in adults can generally be used for 
school-age children.
• Autorefraction
Autorefraction may be used as a starting point 
for subjective refraction, but not as a substitute 
for it; however, retinoscopy, when performed by 
an experienced clinician, is more accurate than 
automated refraction for determining a starting point 
for non-cycloplegic refraction.158 (Evidence Grade: C)
c. Binocular Vision, Ocular Motility, and 
Accommodation
In analyzing the results of these tests, it is important 
to examine all the data and group findings rather than 
depend on a single finding to arrive at a diagnosis. 
Testing in this age group is similar to that for adults and 
may include:
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• Ocular alignment assessment (distance and 
near)
Testing may use the unilateral cover test and 
alternating cover test. If cover test results are 
unreliable because of the child’s resistance 
to testing, use of the Hirschberg test may be 
successful. Prisms can be used with the Hirschberg 
test to align the corneal reflex (Krimsky test) and 
estimate the magnitude of any deviation. Other tests 
include the Von Graefe phoria, Modified Thorington, 
and Maddox Rod.
• Ocular motility assessment
Examination of eye movements in this age group 
involves an assessment of comitancy of fixation, 
saccadic, and pursuit functions. Versions may also 
be performed to rule out a noncomitant deviation.
• Near point of convergence (NPC)
Determination of maximum convergence ability may 
be obtained objectively or subjectively.
• Stereopsis
School-age children should be able to complete 
any of the available random dot stereopsis 
tests. If random dot (global) stereopsis is not 
present, testing should continue to evaluate local 
stereopsis, potential for flat fusion, and potential for 
simultaneous perception.
• Positive and negative fusional vergence ranges
Evaluation should be made of both the amplitude 
and facility of fusional vergence ranges.
• Accommodative testing 
Assessment of accommodation may include 
accommodative amplitude, facility, and 
response.149,159 Testing of negative relative 
accommodation (NRA) and positive relative 
accommodation (PRA) may provide useful 
information on both accommodative and binocular 
status.149
d. Color Vision 
If not done previously, school-age children should be 
tested for color vision deficiency. Color vision deficiency 
can interfere with daily activities involving colors and 
prohibit some occupational choices.160 One-third 
of individuals with abnormal color vision reported 
their career choice had been affected by color vision 
deficiency and one-quarter had been precluded from an 
occupation because of it or had problems in their current 
job.161
CONSENSUS-BASED ACTION STATEMENT: 
Abnormal color vision can affect daily performance 
of activities involving color discrimination and 
may interfere with or prevent some occupational 
choices later in life. Children should be tested as 
soon as possible for color vision deficiency and the 
parents/caregivers of children identified with color 
vision deficiency should be counseled.
Evidence Quality: There is a lack of published 
research to support or refute the use of this 
recommendation.
Benefit and Harm Assessment: Implementation 
of this recommendation is likely to increase early 
detection of color vision deficiency and alert 
parents/caregivers to any potential effects on a 
child’s education or occupational choices. The 
benefits of this recommendation were established 
by expert consensus opinion.
5. Ocular and Systemic Health Assessment
Thorough assessment of the health of the eyes and 
associated structures is an important and integral 
component of the comprehensive pediatric eye and 
vision examination. The eyes and associated structures 
are not only sites for primary ocular diseases, but they 
are also subject to systemic disease processes that 
affect the body as a whole (e.g., disorders of neurologic, 
vascular, endocrine, immune, or neoplastic origin).
Standard procedures used in evaluating adult patients 
may need to be modified or may not be optimal 
in very young patients. With some modifications, 




the components of the ocular and systemic health 
assessment may include:
a. Assessment of Pupillary Responses
Evaluation of pupils includes size, shape, symmetry, 
and direct and consensual response to light and relative 
afferent pupillary defect.
b. Visual Field Evaluation 
Confrontation visual field testing can be used to detect 
gross peripheral defects and areas of constricted visual 
fields. 
c. Evaluation of the Ocular Anterior Segment and 
Adnexa
Assessment of the external eye and adnexa, ocular 
surface, anterior chamber, and crystalline lens.
d. Evaluation of the Ocular Posterior Segment
Pharmacological dilation of the pupil is generally required 
for thorough stereoscopic evaluation of the ocular 
media, retinal vasculature, macula, optic nerve, and the 
peripheral retina.162 (Evidence Grade: B)
Examination under general anesthesia may be 
considered under rare circumstances, if the retina cannot 
be adequately visualized during an examination of at-risk 
children.163
e. Measurement of Intraocular Pressure 
Measuring intraocular pressure (IOP) is a part of the 
comprehensive pediatric eye and vision examination. 
Although the prevalence of glaucoma is low in children, 
measurement of IOP should be attempted. Pressure 
should be assessed when ocular signs and symptoms or 
risk factors for glaucoma exist. If risk factors are present 
and reliable assessment of IOP under standard clinical 
conditions is impossible, testing under anesthesia may 
be indicated. Recording of tonometry results should 
include method used and time of day.164 (Evidence 
Grade: C) 
Clinical note: The Goldmann applanation 
tonometer (GAT) is considered the reference 
standard for the measurement of IOP; however, 
its use may not be practical in very young 
children. Non-contact and handheld applanation 
tonometers can provide IOP measurements close 
to that of the Goldmann.165 (Evidence Grade: A) 
Rebound tonometry offers an advantage over 
GAT in that it is portable, easy to use, and better 
tolerated.166 (Evidence Grade: B)
6. Supplemental Testing
During an eye and vision examination, the information 
obtained from the patient is continually assessed, along 
with the clinical findings gathered. The interpretation of 
subjective and objective data may indicate the need for 
additional testing.
Additional testing may be indicated to: 
• Confirm or rule out differential diagnoses
• Enable more in-depth assessment
• Provide alternative means of evaluating patients 
who may not be fully cooperative or who may 
not comprehend testing procedures.
Supplemental procedures may be performed 
immediately or during subsequent examinations. 
Supplemental testing for infants and children may 
include:
a. Electrodiagnostic Testing
Electrophysiological techniques may be used to assess 
children with unexplained reduced vision. Testing may 
include an electroretinogram (ERG) or measurement of 
visual evoked potential (VEP).
b. Imaging
The following procedures may be used for imaging of 
ocular structures:
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• Ultrasonography can reveal congenital 
anatomical abnormalities in the eye and orbit, 
as well as anatomical changes secondary to 
disease or injury, and measure axial length 
• Optical coherence tomography (OCT) provides 
cross-sectional, high-resolution imaging of the 
anterior and posterior segments 
• Scanning laser ophthalmoscopy provides 3-D 
images of the optic nerve head
• Fundus photography, with or without auto 
fluorescence, is a noninvasive diagnostic 
technique for examining the fundus
• Corneal topography provides an assessment of 
corneal thickness, shape, power, and surface 
details 
• Computerized tomography (CT) scan, 
magnetic resonance imaging (MRI), and other 
neuroimaging may be indicated for suspicion of 
neurological disease or trauma/injury 
• Scheimpflug camera for anterior segment 
tomography (Pentacam, Orbscan, and Gallilei) 
may be used for detection of keratoconus.
c. Testing for Learning-related Vision Problems 
Vision problems such as accommodative, binocular 
vision, eye movement, and visual information processing 
disorders can interfere with academic performance. 
When a child’s history or initial testing indicates a 
possible developmental lag or learning disorder, 
additional testing should be performed to rule out a 
learning-related vision disorder. This will typically require 
an additional office visit that includes more extensive 
testing of accommodation, binocular vision, and eye 
movements, and an assessment of visual information 
processing skills. In some instances, this may require a 
referral to a doctor of optometry with advanced training 
in this area of practice.
CONSENSUS-BASED ACTION STATEMENT: 
Children at risk for learning-related vision problems 
should be evaluated by a doctor of optometry. 
Evidence Quality: There is a lack of published 
research to support or refute the use of this 
recommendation. 
Benefit and Harm Assessment: Implementation 
of this recommendation is likely to result in more 
in-depth evaluation and diagnosis of children with 
learning-related vision problems. The benefits of 
this recommendation were established by expert 
consensus opinion.
Click to view the (AOA Clinical Practice Guidelines 
web page)
7. Children with Special Needs
a. At-risk Children 
In the United States, the Individuals with Disabilities 
Education Act (IDEA) allows for the development of 
Individualized Education Programs (IEPs) when indicated.
The following categories of children are considered high-
risk (Health and Human Services, Health Resources 
and Services Administration, Maternal and Child 
Health Bureau) and recommend direct referral for a 
comprehensive eye and vision examination:
• Children with obvious evidence of physical 
anomaly (e.g., strabismus, ptosis, nystagmus)
• Children with central nervous system (CNS) 
dysfunction (e.g., cerebral palsy, Down 
syndrome, seizures, developmental delay)
• Children with Autism Spectrum Disorder 
• Children enrolled in Early Intervention (EI) 
Program’s
a). Children with an IEP 
b). Children enrolled in Early Head Start (ages 
0-3)
• Children with a family history of amblyopia, 
strabismus, or other early eye disease




• Children born from high-risk pregnancy (e.g., 
maternal drug use, infection during pregnancy, 
preterm delivery).
b. Developmental Disabilities 
Many children with special needs have undetected 
and untreated visual problems 167 (see Appendix 
Table 4: Partial Listing of Ocular Manifestations of 
Neurodevelopmental Disorders and Other Syndromes). 
Children with developmental or intellectual disabilities 
have a higher rate of vision disorders and should 
receive a comprehensive pediatric eye and vision 
examination.21, 25, 168 Although clinically more challenging, 
visual assessment is possible in the majority of these 
children.167 (Evidence Grade: B),169 (Evidence Grade: 
B) Early identification of specific visual deficits could 
lead to interventions to improve the educational and 
occupational achievement and quality of life for these 
high-risk children.
CONSENSUS-BASED ACTION STATEMENT: 
Many children with developmental or intellectual 
disabilities have undetected and untreated vision 
problems and should receive a comprehensive 
pediatric eye and vision examination.
Evidence Quality: There is a lack of published 
research to support or refute the use of this 
recommendation. 
Benefit and Harm Assessment: Implementation 
of this recommendation is likely to result in 
improved quality of life and educational and 
occupational achievement for these high-risk 
children. The benefits of this recommendation 
were established by expert consensus opinion.
8. Trauma and Ocular Manifestations of Child 
Abuse/Neglect
a. Trauma (Accidental)
A majority of concussions occur in the pediatric and 
adolescent population (5 to 17 years of age), with 
the 11 to 17-year-old group representing the largest 
proportion of those injured.170, 171 Children are particularly 
vulnerable to the consequences of concussion, often 
having a more prolonged recovery and poorer outcomes, 
from a cognitive and developmental perspective, than 
adults with concussion.172-175 A recent study found 
a high prevalence of vision problems in adolescents 
with concussion along with significant symptoms 
associated with these vision disorders.176 The most 
common binocular vision disorder occurring in post-
concussion syndrome is convergence insufficiency (CI) 
with a prevalence of 49% in children. Other common 
problems are accommodative insufficiency and saccadic 
dysfunction. 
All children with concussion should see their general 
practitioner in the event they should need more emergent 
care and should be scheduled for a comprehensive eye 
examination to confirm visual capabilities are protected. 
b. Ocular Manifestations of Child Abuse and Neglect 
(Non-accidental)
External eye trauma (e.g., conjunctival hemorrhages, 
lid lacerations, corneal scars and/or opacities) and 
retinal trauma (e.g., hemorrhages, folds, tears, and/
or detachments) are common ocular findings from 
child abuse and can have an important role in its 
diagnosis.177-180 Most often the child is between 2 and 18 
months of age at the time of abuse.179, 181
The eyes can be direct or indirect targets of child abuse 
and may provide valuable diagnostic information, 
particularly when there are limited external signs 
of abuse. In children, the leading cause of retinal 
hemorrhages with retinal folds and macular retinoschisis, 
in the absence of skull fractures or automobile accident 
history, is typically abusive head trauma.182, 183 Retinal 
hemorrhages, poor visual response, and poor pupil 
response in an infant may indicate abusive head trauma, 
or Shaken Baby Syndrome,177 (Evidence Grade: B),178 
(Evidence Grade: C) a form of child abuse in which the 
child is injured secondary to violent shaking. 
A vague history provided by the parent/caregiver that 
changes on re-questioning or is inconsistent with the 
age of the child or extent of the injury should be an alert 
for abuse. In such cases, a detailed history is one of 
the most important factors to consider when assessing 
whether a child has been abused.180
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Table 5: Summary of the Signs of Child Abuse and Neglect
Ocular signs of abuse General physical signs of abuse or neglect
Emotional and behavioral signs 
of abuse or neglect
Cortical blindness
Ruptured globe
Retinal, preretinal, vitreous hemorrhages 
particularly if child is less than 2  
years old
























Eyelash infestation with phthirus pubis  
(crab louse)
Bruises around cheeks, jaw, eyes, ears, or 
mastoid area
Soft tissue bruises on upper arms, thighs, 
buttocks or genitals
Hair loss with/without subgaleal menatoma
Torn frenum of upper lip
Torn floor of mouth
Burns on any posterior part of the body, 
particularly buttocks, perineum, hands, 
or feet
Full thickness burns




Signs of malnutrition such as sunken 
cheeks and buttocks, distended 
abdomen
Child not properly immunized
Venereal disease in a preadolescent child
Case history inconsistencies
No history offered
History vague or inconsistent with injuries
History changes during course of 
examination
History varies between two parents or 
between parents and child
Multiple office visits for accidental injuries
Increase in severity of injuries
Delay in seeking medical attention
Frozen watchfulness
Fear of strangers






Impaired ability to enjoy life
Social withdrawal
Learned helplessness
Suicidal ideation or attempts












Source: Smith S. Child abuse and neglect: A diagnostic guide for the optometrist. J Amer Optom Assoc 1988; 
59:760-66.
All 50 states and the District of Columbia have laws mandating the reporting of suspected child abuse and provide 
penalties for failure to do so. 
U.S. Department of Health and Human Services, Administration for Children & Families, Children’s Bureau listing of 
state child abuse and neglect reporting numbers
Clinical note: Doctors of optometry should be aware of the eye-related findings associated with abusive head 
trauma and report findings of possible child abuse to the proper authorities, as defined by state law, for the 
protection of the child.




9. Potential Benefits and Harms of Testing
The potential benefits of a comprehensive pediatric eye 
and vision examination include:
• Optimizing visual function through diagnosis, 
treatment, and management of refractive, ocular 
motor, accommodative, and binocular vision 
problems
• Preventing and/or minimizing vision loss through 
early diagnosis, treatment, and management of 
ocular health conditions
• Detecting systemic disease and referring for 
appropriate care
• Counseling and educating patients/parents/
caregivers on current conditions and preventive 
care to maintain ocular and systemic health and 
visual function, and on the relationship between 
vision problems and early learning.
Potential harms associated with a comprehensive 
pediatric eye and vision examination may include:
• Patient or parent/caregiver anxiety about testing 
procedures or resulting diagnosis
• Adverse ocular and/or systemic reactions and/
or temporary visual disturbances resulting from 
testing, or allergic responses to diagnostic 
pharmaceutical agents or materials used
• Missed or misdiagnosis of eye health or vision 
problems
• Unnecessary referral or treatment.
B. ASSESSMENT AND DIAGNOSIS
At the completion of the examination, the data collected 
should be assessed and evaluated to establish a 
diagnosis (or diagnoses) and formulate a treatment 
and management plan. The nature and severity of the 
problem(s) diagnosed determine the need for optical 
prescription (e.g., eyeglasses and/or contact lenses) or 
other treatment (e.g., vision rehabilitation, vision therapy, 
ocular pharmaceuticals). 
C. MANAGEMENT
1. Prescription for Correction
A prescription for correction of refractive error, if needed, 
is provided at the conclusion of the examination.184 The 
level of refractive error may be monitored rather than 
prescribed as a lens correction, or full or partial optical 
correction may be prescribed, depending on the specific 
visual needs, refractive measurement, and related visual 
findings.
2. Additional Treatment Services
Depending on the diagnosed eye and vision condition(s), 
other treatment services may be needed. For conditions 
such as accommodative, binocular vision, eye 
movement, visual information processing disorders, or 
visual impairment, treatment such as the use of prisms, 
vision therapy, or vision rehabilitation may be necessary. 
Ocular pharmaceuticals may also be used for the 
treatment of various eye diseases.
3. Counseling and Education
It is important for children/parents/caregivers to 
understand the medical information and 
recommendations given to them. To enhance 
understanding, open-ended questions should be used. 
Children/parents/caregivers should be asked to state 
their understanding of the information given to them 
using their own words.185 Eye models, diagrams, and 
written materials can also be used to aid in 
understanding. 
Shared decision-making increases patient/parent/
caregiver satisfaction with the examination and 
consultation, and may improve health outcomes. The 
available options, with their benefits and risks, need to 
be described and patient/parent/caregiver views and 
preferences elicited, before agreeing on a course of 
action.186
Language and cultural differences or misunderstandings 
may prevent some individuals from accepting a doctor’s 
recommendation. When communicating with patients/
parents/caregivers, it is important to take their level of 
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“health literacy” into consideration.187 Health literacy is 
“the degree to which individuals have the capacity to 
obtain, process, and understand basic health information 
and services needed to make appropriate decisions 
regarding their health.”188 Limited health literacy has been 
associated with a range of adverse health outcomes 
including decreased use of preventive services and poor 
disease specific outcomes.189 
In addition, anxiety reduces the effectiveness of 
patient-practitioner communications and results in 
reduced attention, recall of information, and compliance 
with treatment. The use of “patient-centered” 
communications and “active listening” can help 
reduce anxiety and improve patient/parent/caregiver 
satisfaction and outcomes.190 Improved doctor-patient 
communications and higher levels of patient/parent/
caregiver involvement in care are linked to better clinical 
outcomes.191
In compliance with the Americans with Disabilities Act 
(ADA), reasonable accommodations need to be made 
to ensure that whatever is written or spoken is clear 
and understandable to individuals with disabilities. 
Appropriate auxiliary aids and services must be 
made available, when needed, to enable effective 
communications when evaluating, treating, or counseling 
persons with hearing, vision, or speech impairments. 
According to the ADA, auxiliary aids and services for 
individuals who are hearing impaired include qualified 
interpreters, note takers, computer-aided transcription 
services, written materials, telephone handset amplifiers, 
assistive listening systems, telephones compatible with 
hearing aids, closed caption decoders, open and closed 
captioning, telecommunications devices for the deaf 
(TDD’s), videotext displays and exchange of written 
notes. For individuals with vision impairments, auxiliary 
aids and services include qualified readers, taped texts, 
audio recordings, magnification software, optical readers, 
Braille materials, and large print materials. Examples 
for individuals with speech impairments include 
TDD’s, computer terminals, speech synthesizers, and 
communication boards.192
Language interpreters may also be needed to assist 
patients who have limited English proficiency. Family 
members of patients may act as interpreters, with the 
parent/caregiver consent for minors.
CONSENSUS-BASED ACTION STATEMENT: 
At the conclusion of a comprehensive pediatric 
eye and vision examination, the diagnosis should 
be explained to the patient/parent/caregiver and 
related to the patient’s symptoms, and a treatment 
plan and prognosis discussed.
Evidence Quality: There is a lack of published 
research to support or refute the use of this 
recommendation
Benefit and Harm Assessment: Implementing 
this recommendation is likely to increase patient/
parent/caregiver understanding of any diagnosed 
eye or vision problems and improve compliance 
with any recommended treatment. The benefits of 
this recommendation were established by expert 
consensus opinion
Patient/parent/caregiver counseling and education may 
include:
• Review of the child’s visual and ocular health 
status in relation to his/her visual symptoms and 
complaints
• Discussion of any refractive correction that 
provides improved visual efficiency and/or 
appropriate eye protection
• Information on learning-related vision problems
• Explanation of available treatment options for 
diagnosed eye or vision conditions, including 
risks, benefits, and expected outcomes
• Recommendation of a course of treatment with 
the reasons for its selection and the prognosis
• Discussion of the importance of patient 
compliance with the treatment prescribed
• Recommendation for follow-up care, re-
examination, or referral.
When appropriate, patients/parents/caregivers should 
also be counseled about:




a. Eye Safety and Protection
Eye injury is a leading cause of monocular blindness in 
the United States and a common reason for eye-related 
emergency department visits. Eye injuries treated in U.S. 
hospital emergency rooms among children younger than 
18 years of age averaged over 70,000 annually in 1990 
through 2009.193 (See Table 6.) The risk for eye injuries in 
children is highest among 15 to 17 year olds. The most 
common eye injuries are due to abrasions or foreign 
bodies.194
The majority of eye injuries in children occur at home.193 
Frequent causes are sports and recreation activities, 
chemicals, or household products.193,195 Most eye injuries 
are preventable with appropriate use of protective 
eyewear;196, 197 however, in a National Health Interview 
Survey of children participating in activities that can 
cause eye injury, only 14.5% were reported to wear 
protective eyewear all or most of the time. Older children 
(12 to 17 years of age) were more likely to use protective 
eyewear than younger children.198
Table 6: Most Common Pediatric Eye Injuries 
Treated in U.S. Emergency Departments 
Common Pediatric Eye Injuries
Sports and recreation (e.g., basketball, baseball, football, playground 
equipment)
Household chemicals (e.g., cleaning agents, bleach, pesticides)
Housewares and furniture (e.g., microwaves, flatware, tables)
Toys
Desk supplies (e.g., pens, pencils, scissors)
Tools and hardware (e.g., hammers, nails)
BB and pellet guns
Tobacco products (e.g., cigarettes, cigars, pipes)
Fireworks
Source: Rankings of common pediatric eye injuries 
as reported in Pediatric eye injuries treated in U.S. 
emergency departments, 1990-2009.193
It is important to discuss eye safety issues with children/
parents/caregivers, including eye hazards at school 
or home, and during sports and recreational activities, 
and to promote the use of appropriate protective 
eyewear to help reduce the incidence of eye injuries 
among children.193 (Evidence Grade: B),199 (Evidence 
Grade: B) Prevention strategies should focus on the 
use of protective eyewear, parental supervision, and on 
childhood education about both the risks of eye injury 
and the utility of protective eyewear.194 (Evidence Grade: 
B) 200
EVIDENCE-BASED ACTION STATEMENT: 
Parents/caregivers and children should be 
educated about potential risks for eye injuries 
at home, at school, and during sports and 
recreational activities, and advised about safety 
precautions to decrease the risk of ocular 
injury.193,199 Prevention of eye injuries in children 
should focus on the use of protective eyewear, 
parental supervision, and include education about 
both the risks of eye injury and the benefits of 
protective eyewear.194
Evidence Quality: Grade B: Retrospective cohort 
studies
Level of Confidence: Medium
Clinical Recommendation Strength: Strong 
Recommendation. This recommendation should 
be followed unless clear and compelling rationale 
for an alternative approach is present.
Evidence Statements: It is important to 
discuss eye safety issues with children/parents/
caregivers.193 (Evidence Grade: B),199 (Evidence 
Grade: B) 
Prevention strategies should focus on the use 
of protective eyewear, parental supervision, and 
on childhood education about both the risks of 
eye injury and the utility of protective eyewear.194 
(Evidence Grade: B)
Potential Benefits: 




Benefit and Harm Assessment: Benefits 
significantly outweigh harms
Potential Costs: Direct cost of counseling as part 
of a pediatric eye and vision examination
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Value Judgments: None
Role of Patient Preferences: Large
Intentional Vagueness: Specific type/form of 
counseling is not stated, as it is patient specific
Gaps in Evidence: Research is needed to 
determine the risks and methods of eye protection 
associated with specific eye injuries in children in 
order to design appropriate prevention strategies
b. Ultraviolet Radiation and Blue Light Protection 
Children/parents/caregivers should be advised about the 
need to protect children’s eyes from excessive exposure 
to sunlight. Sunlight is comprised of ultraviolet (UVA 
and UVB) radiation and short wavelength visible energy 
(blue light), which can cause acute effects in the eye 
and may also lead to chronic effects over the life of the 
individual. The eyes of infants and young children are 
known to have a higher level of UV and short wavelength 
transmittance than older children and adults, making 
them more susceptible to energy-related injury.201, 202
Exposure to high levels of UV-containing sunlight, 
especially when reflected from snow, can cause 
acute photokeratitis and keratoconjunctivitis. Chronic 
exposure to even low levels of UV radiation is a risk 
factor for developing cataracts, pterygium, squamous 
cell carcinoma of the cornea and conjunctiva, and skin 
cancer.203 Epidemiological evidence also shows that 
excess chronic sunlight exposure leads to a significantly 
increased risk for developing age-related macular 
degeneration as an older adult.204
Exposure to high levels of short wavelength visible 
energy (blue light) also has the potential to cause 
photochemical retinal damage, which is known to occur 
with direct sun viewing.205, 206 In addition, the increased 
evening use of laptops and other broad spectrum self-
illuminated devices rich in blue light has been suggested 
to interfere with good sleep hygiene, especially in 
adolescents.207
Children can reduce the potential for eye damage from 
UV radiation and blue light by not looking directly at the 
sun, and wearing sunglasses and/or clear prescription 
lenses and brimmed hats when outdoors. 
CONSENSUS-BASED ACTION STATEMENT: 
All children and their parents/caregivers should 
be advised about the benefits of the regular use 
of sunglasses and/or clear prescription glasses 
that effectively block at least 99% of UVA and 
UVB radiation, the use of hats with brims when 
outdoors, and the importance of not looking 
directly at the sun.
Evidence Quality: There is a lack of published 
research to support or refute the use of this 
recommendation.
Benefit and Harm Assessment: Implementing 
this recommendation is likely to decrease patient 
risk of eye health problems from acute or chronic 
exposure to UV radiation and blue light. The 
benefits of this recommendation were established 
by expert consensus opinion.
c. Impact of Near Work and Reduced Time Outdoors 
on Vision
The prevalence of myopia in children has been increasing 
significantly in the past few decades.44 Environmental 
factors such as time spent on reading and other near 
activities and the limited amount of time spent outdoors 
have been cited as potential factors contributing to 
the development and progression of myopia.208 Most 
children spend considerable time each day using 
computers, tablets, or smart phones at school and 
at home. As a result, they may be spending less time 
outdoors. 
Although there is conflicting evidence, more time spent 
outdoors and less time indoors doing near work may 
slow myopia progression and prevent high myopia.208 
(Evidence Grade: A),209 (Evidence Grade: B),210 (Evidence 
Grade: B),211 (Evidence Grade: D).212
EVIDENCE-BASED ACTION STATEMENT: 
Patients/parents/caregivers should be counseled 
about the benefits to children’s vision of spending 
more time outdoors.208-211




Evidence Quality: Grade B. Randomized clinical 
trial, Prospective cohort studies, Cross-sectional 
study 
Level of Confidence: Medium
Clinical Recommendation Strength: 
Recommendation. This recommendation should 
generally be followed, but remain alert for new 
information.
Evidence Statements: More time spent outdoors 
and less time indoors doing near work may slow 
axial elongation and prevent high myopia thereby 
reducing the risk of developing sight-threatening 
conditions such as retinal detachment and myopic 
retinopathy.208 (Evidence Grade: A)
More time outside may decrease myopia 
progression. Less outdoor/sports activity before 
myopia onset may exert a stronger influence on 
the development of myopia than near work.209 
(Evidence Grade: B)
Outdoor time and near work do not have a major 
effect on myopia progression.210 (Evidence Grade: 
B)
Higher levels of outdoor activity were associated 
with lower amounts of myopia in primary school 
students.211 (Evidence Grade: D)
Potential Benefits: 
Implementation of this 
recommendation is 
likely to help reduce 
the development and 




Benefit and Harm Assessment: Benefits 
significantly outweigh harms
Potential Costs: Direct cost of counseling as 
part of a pediatric eye and vision examination and 
parental/caregiver time off from work
Value Judgments: None
Role of Patient Preferences: Moderate
Intentional Vagueness: Specific type/form of 
counseling is not stated, as it is patient specific
Gaps in Evidence: Research is needed on the 
effects and possible interaction of outdoor activity 
and near work on myopia in children
d. Myopia Control
Childhood is the preferred time to consider the use of 
myopia control procedures, as early onset myopia is 
associated with higher progression rates and increased 
risk of continuing to high myopia.213
The use of progressive addition spectacle lenses, 
prismatic bifocals, multiple and dual focus contact 
lenses, orthokeratology, and atropine have been studied 
to slow myopia progression.214 The approaches to 
control of myopia that have been shown in studies to 
be most successful are the use of low concentrations of 
atropine eye drops 215 and orthokeratology.214, 216, 217.
Parents/caregivers of children who are at risk for 
developing or have developed myopia should be 
counseled about the potential complications of myopia 
progression and the treatment options available for its 
control. 
4. Coordination and Frequency of Care
The diagnosis of a wide array of eye and vision 
anomalies, diseases, disorders, and related systemic 
conditions may result from a comprehensive pediatric 
eye and vision examination. The nature and severity of 
the problem(s) diagnosed determine the need for:
• Optical correction
• Vision therapy
• Vision rehabilitation services
• Prescription or nonprescription medications 
• Surgery
• Follow-up for additional evaluation and/or 
treatment.
a. Coordination of Care
Based on the examination, it may be determined that the 
patient needs additional services. These may include:
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• Intraprofessional consultation with another 
doctor of optometry for treatment and 
management of ocular disease, vision 
rehabilitation, vision therapy, and/or specialty 
contact lenses.
• Interprofessional consultation with an 
ophthalmologist may be necessary for 
ophthalmic surgery or other aspects of 
secondary or tertiary eye care.
• Some vision problems can interfere with 
learning. Children at risk for learning-related 
vision problems should be evaluated by a doctor 
of optometry.
• Referral for consultation with the child’s 
pediatrician or other primary care physician, 
developmental pediatrician, pediatric neurologist, 
the school system, a child psychologist or 
psychiatrist, or the local or state Department of 
Special Education should be considered when 
problems in other developmental areas such as 
behavior, language, or social development are 
suspected or when a full psychoeducational 
evaluation is indicated.
• The comprehensive pediatric eye and vision 
examination may reveal non-ophthalmic 
conditions for which coordination of care may 
be needed. The patient may be referred to 
his or her pediatrician/primary care physician 
or another health care provider for further 
evaluation and treatment of systemic conditions 
or related health problems. Information shared 
with other health care providers offers a unique 
and important perspective resulting in an 
improved team approach to interdisciplinary care 
of the patient.
• Ocular telehealth programs may be a 
component of care for some patients, 
particularly in areas where access to specialized 
eye care services is limited. The use of ocular 
telehealth-based programs has the potential 
to expand access to eye care services; 
however, telehealth-based evaluations are not 
a substitute for an in-person comprehensive 
eye examination. These programs rely on the 
digital capture and transmission of standardized 
ocular images and patient health information at 
one location for interpretation and evaluation at 
another location by trained observers who can 
recommend a treatment and care plan. To date, 
telehealth programs have been most widely 
used for the evaluation of patients with diabetic 
retinopathy.218
b. Frequency of Care
Children should receive periodic eye and vision 
examinations to diagnose and treat any eye disease in 
its early stages in order to prevent or minimize vision 
loss and maximize visual abilities. These examinations 
can also identify problems that may be affecting visual 
function and achievement at school, at home, and in 
sports or leisure activities. In addition, the early signs 
and symptoms of systemic medical conditions, such 
as diabetes, may be revealed during a comprehensive 
pediatric eye and vision examination. 
The recommended frequency of a comprehensive 
pediatric eye and vision examination (Table 7) varies 
with a child’s age, ocular and medical history, and other 
related risk factors.
• Infants and Toddlers (newborn through 2 years 
of age)
Clinical experience and research have shown that at 
6 months the average child has reached a number 
of critical developmental milestones, making this an 
appropriate age for the first eye and vision examination. 
Within the first 6 months of life, rapid changes occur 
in most components of the visual system including 
visual acuity,121, 219 accommodation,220, 221 and binocular 
vision.222-224 Since the developing visual system is 
considered most susceptible to interference during the 
first few years of life,225-227 interference during this critical 
phase of development may have significant long-term 
effects; therefore, early diagnosis and treatment are 
critical to avoid vision loss.
There is a high prevalence of eye and vision problems 
in preterm children.228 Preterm infants with a history of 
retinopathy of prematurity should be closely monitored 
for the development of high myopia, astigmatism, 




anisometropia,229 (Evidence Grade: B) strabismus,76 and 
other ocular diseases.
One of the primary goals of examining young children is 
to detect amblyopia so that treatment can be initiated 
as early as possible. Early visual examination of infants 
for amblyopia and amblyopic risk factors can lower 
the prevalence and severity of amblyopia in children.230 
(Evidence Grade: B) 
Assessment of infant refractive error can identify not 
only vision problems, but also potential developmental 
difficulties. Infants with hyperopia may show deficits 
in many visuocognitive, spatial, visuomotor, and 
attention tests.231 (Evidence Grade: B) Significant 
hyperopia is commonly found in association with the 
early development of strabismus and amblyopia, with 
increased risk of development by age 4 years.
The wearing of a partial correction for significant 
hyperopia and anisometropia throughout infancy can 
reduce the incidence of poorer than average visual acuity 
in 3 to 5 1/2 year olds.232 Spectacle correction in infancy 
also improves the chances of infants with hyperopia 
having normal vision at age 4 and beyond.233
EVIDENCE-BASED ACTION STATEMENT: 
Infants should receive an in-person comprehensive 
eye and vision assessment between 6 and 12 
months of age for the prevention and/or early 
diagnosis and treatment of sight-threatening eye 
conditions and to evaluate visual 
development.229-231
Evidence Quality: Grade B: Prospective cohort 
studies, Diagnostic study
Level of Confidence: High
Clinical Recommendation Strength: Strong 
Recommendation. This recommendation should 
be followed unless clear and compelling rationale 
for an alternative approach is present.
Evidence Statements: Preterm infants with a 
history of retinopathy of prematurity should be 
closely monitored for the development of high 
myopia, astigmatism, and anisometropia.229 
(Evidence Grade: B)
Early visual examination in infants for amblyopia 
and amblyopic risk factors can lower the 
prevalence and severity of amblyopia in children.230 
(Evidence Grade: B)
Assessment of infant refractive error can identify 
not only vision problems, but also potential 
developmental difficulties. Hyperopic infants may 
show deficits in many visuocognitive, spatial, 
visuomotor, and attention tests.231 (Evidence 
Grade: B)
Potential Benefits: 
Early identification and 




Benefit and Harm Assessment: Benefits 
significantly outweigh harms
Potential Costs: Direct cost of testing and 
parent/caregiver time off from work
Value Judgments: None
Role of Patient Preferences: Moderate
Intentional Vagueness: None
Gaps in Evidence: None identified
• Preschool Children (3 through 5 years of age)
Vision care in preschool children is very important 
because their visual system is still developing. They are 
at risk for the development of amblyopia, strabismus, 
and refractive error, which may lead to long term visual 
impairment.40, 41, 53, 234-236
Amblyopia is a treatable condition in children and 
adolescents 54 (Evidence Grade: A); however, amblyopia 
is more responsive to treatment among children younger 
than 7 years of age.54-60 Significant uncorrected refractive 
errors are a risk factor for the development of amblyopia. 
In addition to its impact on vision, amblyopia can affect 
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an individual’s psychosocial functioning, warranting early 
diagnosis and treatment.19
Uncorrected refractive errors have been associated with 
delays in development of cognitive ability and motor 
skill.10, 231, 237 The Vision in Preschoolers-Hyperopia in 
Preschoolers (VIP-HIP) study found that uncorrected 
hyperopia ≥4.00D, as well as uncorrected hyperopia 
≥3.00D to ≤6.00D in conjunction with reduced 
binocular visual acuity (20/40 or worse) or reduced 
near stereoacuity (240 seconds of arc or worse), are 
associated with significantly worse performance on 
a test of preschool early literacy (TOPEL) in 4 and 
5 year old children.238 (Evidence Grade: C) Children 
with astigmatism tend to score lower on measures of 
academic and developmental skills than children without 
astigmatism.239 Spectacle correction of children with 
astigmatism during the preschool years can also result in 
significantly improved best-corrected visual acuity by the 
time they reach kindergarten age.240 (Evidence Grade: C)
Uncorrected vision problems can have a detrimental 
effect on vision development, learning, school success, 
and socialization. Many eye and vision problems are 
asymptomatic in this age range; therefore, it is important 
that preschool children receive a comprehensive eye 
examination. While the U.S. Preventive Services Task 
Force recommends that children have their vision 
screened at least once between the ages of 3 and 5 
years,107 (Evidence Grade: B) gaps exist in the delivery 
of preschool vision screening. Rates of vision screening 
in preschool children are low, particularly in 3 year old 
children.241 (Evidence Grade: C)
EVIDENCE-BASED ACTION STATEMENT: 
Preschool age children should receive an in-person 
comprehensive eye and vision examination at least 
once between the ages of 3 and 5 to prevent and/
or diagnose and treat any eye or vision conditions 
that may affect visual development.54,107, 238, 240, 241
Evidence Quality: Grade B. Systematic Review, 
Case series, Cross-sectional study
Level of Confidence: Medium
Clinical Recommendation Strength: Strong 
Recommendation. This recommendation should 
be followed, unless clear and compelling rationale 
for an alternative approach is present.
Evidence Statements: Amblyopia is a treatable 
condition in children and adolescents 54 (Evidence 
Grade: A); however amblyopia is more responsive 
to treatment among children younger than 7 years 
of age. 
Uncorrected hyperopia in 4 and 5 year old 
children has been associated with delays in the 
development of early literacy.238 (Evidence Grade: 
C)
Spectacle correction of astigmatism during the 
preschool years can result in significantly improved 
best-corrected visual acuity by kindergarten age.240 
(Evidence Grade: C) 
The U.S. Preventive Services Task Force 
recommends that children have their vision 
screened at least once between the ages of 
3 and 5 years of age;107 (Evidence Grade: B) 
however, gaps exist in the delivery of preschool 
vision screening and rates of screening are low, 
particularly in 3 year old children.241 (Evidence 
Grade: C)
Potential Benefits: 
Early identification and 




Benefit and Harm Assessment: Benefits 
significantly outweigh harms
Potential Costs: Direct cost of testing and 
parent/caregiver time off from work
Value Judgments: None
Role of Patient Preferences: Moderate
Intentional Vagueness: None
Gaps in Evidence: None identified




• School-age Children (6 through 11 and 12 
through 18 years of age)
Vision may change frequently during the school years. 
The most common problems are due to the 
development and progression of refractive errors.  
Myopia generally occurs in children during their early 
school years and increases in magnitude as they get 
older. If myopia is defined as 0.50D or more, the 
percentage of children becoming myopic is estimated to 
be 23.4%. The age at onset ranges from 7 to 16 years. 
Sixteen percent of children enrolled in the CLEERE study 
developed myopia (0.75D or more) during their school-
age years. The highest percentage of new cases 
occurred at age 11.42
Children should receive an eye examination at the 
beginning of primary school to test for the presence 
of myopia 115 (Evidence Grade: B) and, if diagnosed, 
they should have a comprehensive examination at least 
annually or as frequently as their doctor recommends 
because of rapid myopia progression.242 (Evidence 
Grade: B) Children with myopia, especially those younger 
than 9 years of age and/or with two parents with myopia, 
are at higher risk for myopia progression and should be 
examined more than once per year.208 (Evidence Grade: 
A)
In addition to its relationship to the development of 
strabismus and amblyopia, hyperopia can also affect the 
development of literacy skills. Children with uncorrected 
hyperopia show reduced performance in the acquisition 
of emergent literacy skills.238 (Evidence Grade: C),243 
(Evidence Grade: C) Correction of hyperopia may, under 
specific conditions, lead to increased reading speed; 
therefore, eye examinations to diagnose uncorrected 
hyperopia are recommended.244 (Evidence Grade: B)
An accommodative or vergence dysfunction can have 
a negative effect on a child’s school performance, 
especially after third grade when the child must read 
smaller print and reading demands increase. Children 
with convergence insufficiency self-report more problems 
compared to children with normal binocular vision.245 
These include somatic (e.g., eyes hurt or headaches), 
visual (e.g., blur and diplopia), and performance (e.g., 
loss of concentration, frequent need to re-read and 
difficulty remembering what is read) problems. Due to the 
discomfort of these symptoms, a child may not be able 
to complete reading or homework assignments and may 
be easily distracted or inattentive.
Studies have reported an association between reading 
and eye movements.246-248 Efficient reading requires 
accurate eye movements. Treatment of children with eye 
movement problems has been shown to improve reading 
comprehension.248
Diagnosis and treatment of an accommodative or 
vergence problem may reduce the negative impact on 
academic performance.65 (Evidence Grade B) 249 Vision 
therapy has been shown to be effective in improving 
accommodative amplitude and accommodative facility 
in school-age children with symptomatic convergence 
insufficiency and accommodative dysfunction. 
Children with Attention Deficit/Hyperactivity Disorder 
(AD/HD) have been reported to have a much greater 
incidence of CI than those without AD/HD;250 therefore, 
these children may benefit from comprehensive vision 
evaluation to assess the presence of convergence 
insufficiency.251 (Evidence Grade: D) Treatment of 
convergence insufficiency has been associated with 
reduction in the frequency of adverse academic 
behaviors.65 (Evidence Grade B) 67 
Click to view the (AOA Clinical Practice Guidelines 
web page)
EVIDENCE-BASED ACTION STATEMENT: 
School-age children should receive an in-person 
comprehensive eye and vision examination before 
beginning school to diagnose, treat, and manage 
any eye or vision conditions. 65, 115, 238, 243, 244, 251 
Evidence Quality: Grade B. Prospective cohort 
studies, Case-control study, Cross-sectional study.
Level of Confidence: Medium
Clinical Recommendation Strength: Strong 
Recommendation. This recommendation should 
be followed unless clear and compelling rationale 
for an alternative approach is present.
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Evidence Statements: Children should receive 
an eye examination at the beginning of primary 
school to diagnose the onset of myopia.115 
(Evidence Grade: B) 
Hyperopia can affect the development of literacy 
skills. Children with uncorrected hyperopia 
show reduced performance in the acquisition of 
emergent literacy skills.238 (Evidence Grade: C),243 
(Evidence Grade: C)
Correction of hyperopia may, under specific 
conditions, lead to increased reading speed; 
therefore, eye examinations to diagnose 
uncorrected hyperopia are recommended.244 
(Evidence Grade: B)
Early diagnosis and treatment of an 
accommodative or vergence problem may reduce 
the negative impact on academic performance.65 
(Evidence Grade: B) 
Children with AD/HD or related learning problems 
may benefit from comprehensive vision evaluation 
to assess the presence of convergence 
insufficiency.251 (Evidence Grade: D) 
Treatment of convergence insufficiency has been 
associated with reduction in the frequency of 
adverse academic behaviors.65 (Evidence Grade B)
Potential Benefits: 
Early identification and 




Benefit and Harm Assessment: Benefits 
significantly outweigh harms
Potential Costs: Direct cost of testing and 
parent/caregiver time off from work
Value Judgments: None
Role of Patient Preferences: Moderate
Intentional Vagueness: None
Gaps in Evidence: None identified
EVIDENCE-BASED ACTION STATEMENT: 
Children with myopia should have an in-person 
comprehensive eye and vision examination at 
least annually, or as frequently as recommended 
(especially until age 12), because of the potential 
for rapid myopia progression.208, 242
Evidence Quality: Grade B. Randomized clinical 
trial, Prospective cohort study
Level of Confidence: Medium
Clinical Recommendation Strength: Strong 
Recommendation. This recommendation should 
be followed unless clear and compelling rationale 
for an alternative approach is present.
Evidence Statements: Children with myopia 
should have an examination at least annually or as 
frequently as their doctor recommends until the 
age of 12 because of rapid myopia progression.242 
(Evidence Grade: B) 
When both parents have myopia, children are 
at higher risk for progression and should be 
examined more than once per year.208 (Evidence 
Grade: A)
Potential Benefits: 
Early identification and 




Benefit and Harm Assessment: Benefits 
significantly outweigh harms
Potential Costs: Direct cost of testing and 
parent/caregiver time off from work
Value Judgments: None
Role of Patient Preferences: Moderate
Intentional Vagueness: None
Gaps in Evidence: None identified
CONSENSUS-BASED ACTION STATEMENT: 
School-age children should receive an in-person 
comprehensive eye and vision examination 
annually to diagnose, treat, and manage any eye 
or vision problems.




Evidence Quality: There is a lack of published 
research to support or refute the use of this 
recommendation.
Benefit and Harm Assessment: Implementing 
this recommendation is likely to result in earlier 
diagnosis and treatment of eye and vision 
problems and improved visual function. The 
benefits of this recommendation were established 
by expert consensus opinion.
c. At-risk Children
The extent to which a child is at risk for the development 
of eye and vision problems determines the appropriate 
re-evaluation schedule. Children with ocular signs and 
symptoms require a prompt comprehensive examination. 
Furthermore, the presence of certain risk factors may 
necessitate more frequent examinations based on 
professional judgment. Factors placing an infant, toddler, 
or child at significant risk for eye and vision problems 
include: 
• Prematurity, low birth weight, prolonged 
supplemental oxygen at birth
• Family history of myopia, amblyopia, strabismus, 
retinoblastoma, congenital cataracts, metabolic, 
or genetic disease 
• Infection of mother during pregnancy (e.g., 
rubella, toxoplasmosis, venereal disease, 
herpes, cytomegalovirus, or human 
immunodeficiency virus) 
• Maternal smoking, use of alcohol, or illicit drug 
use during pregnancy 
• Cortical visual impairment
• Difficult or assisted labor, which may be 
associated with fetal distress 
• High or progressive refractive error 
• Strabismus 
• Anisometropia 
• Academic performance problems
• Known or suspected neurodevelopmental 
disorders
• Systemic health conditions with potential ocular 
manifestations 
• Wearing contact lenses
• Having functional vision in only one eye
• Eye surgery or previous eye injury
• Taking prescription or nonprescription 
drugs (e.g., over the counter medications, 
supplements, herbal remedies) with potential 
ocular side effects
Table 7: Recommended Eye Examination 






Birth through 2 years
At 6 to12 months  
of age
At 6 to 12 months 
of age or as 
recommended
3 through 5 years
At least once between 
3 and 5 years of age
At least once between 
3 and 5 years of age 
or as recommended
6 through 18 years
Before first grade and 
annually thereafter
Before first grade 
and annually, or 
as recommended, 
thereafter
**The American Optometric Association Clinical 
Practice Guidelines provide more information on 
other eye and vision disorders and their risk factors. 
Click to view the (AOA Clinical Practice Guidelines 
web page)
D. Conclusion
The prevalence of eye and vision disorders is substantial 
in children. Research indicates that early detection and 
intervention are particularly important in children because 
of the rapid development of the visual system in early 
childhood and its sensitivity to interference. When visual 
disorders such as amblyopia, strabismus, non-strabismic 
binocular vision disorders, and significant refractive 
error are undetected, the long-term consequences can 
: Comprehensive Pediatric Eye & Vision Examination
Published by The Athenaeum, 2020
40
lead to significant vision loss, decreased educational 
and occupational opportunities, and reduced quality 
of life. In addition, the cost of providing appropriate 
treatment for longstanding eye and vision disorders may 
be significantly higher than the cost of diagnosing and 
treating these problems early in life. A comprehensive 
pediatric eye and vision examination by a doctor of 
optometry is imperative for the timely diagnosis and 
treatment of eye and vision problems.
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B. APPENDIX TABLE 1
Potential Components of the Comprehensive Eye and Vision Examination for Infants and Toddlers
A. Patient History
1. Nature and history of the presenting problem, including chief complaint
2. Visual and ocular history
3. General health history, including prenatal, perinatal, and postnatal history and review of systems, surgical 
and/or head or ocular trauma history, and any vision or ocular treatment
4. Medication reconciliation, including prescription and nonprescription drugs (e.g., over the counter 
medications, supplements, herbal remedies) and documentation of medication allergies
5. Family ocular and medical histories
6. Developmental history of the child
7. Time spent outdoors, on sports activities, and on near work and screen viewing
8. Names of, and contact information for, the patient’s other health care providers
B. Visual Acuity
1. Preferential looking visual acuity 
2. Fixation preference test




D. Binocular Vision and Ocular Motility
1. Ocular alignment assessment (e.g., cover test, Hirschberg test, Krimsky test)
2. Brückner test
3. Stereopsis (e.g., Preschool Assessment of Stereopsis with a Smile 3 test)
4. Near point of convergence
5. Ocular motility assessment (e.g., versions, eye tracking)
E. Ocular and Systemic Health Assessment
1. Assessment of pupillary responses
2. Visual field evaluation (e.g., confrontation)
3. Evaluation of the ocular anterior segment and adnexa
4. Evaluation of the ocular posterior segment
5. Measurement of intraocular pressure




C. APPENDIX TABLE 2
Potential Components of the Comprehensive Eye and Vision Examination for Preschool Children
A. Patient History
1. Nature and history of the presenting problem, including chief complaint
2. Visual and ocular history
3. General health history, including prenatal, perinatal, and postnatal history and review of systems, surgical 
and/or head or ocular trauma history, and any vision or ocular treatment
4. Medication reconciliation, including prescription and nonprescription drugs (e.g., over the counter 
medications, supplements, herbal remedies) and documentation of medication allergies
5. Family eye and medical histories
6. Developmental history of the child
7. Time spent outdoors, on sports activities, and on near work and screen viewing
8. Names of, and contact information for, the patient’s other health care providers
B. Visual Acuity
1. Symbol optotype or letter matching visual acuity measurement
C. Refraction
1. Static (distance) retinoscopy
2. Cycloplegic retinoscopy
3. Autorefraction
D. Binocular Vision, Ocular Motility, and Accommodation
1. Ocular alignment assessment - distance and near (e.g., cover test, Hirschberg test, Krimsky test)
2. Ocular motility assessment
3. Near point of convergence
4. Stereopsis (e.g., Preschool Assessment of Stereopsis with a Smile 3 test, Randot Preschool test)
5. Positive and negative fusional vergence ranges
6. Accommodative testing (e.g., dynamic retinoscopy)
E. Color vision testing
F. Ocular and Systemic Health Assessment
1. Assessment of pupillary responses
2. Visual field evaluation (e.g., confrontation)
3. Evaluation of the ocular anterior segment and adnexa
4. Evaluation of the ocular posterior segment
5. Measurement of intraocular pressure
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D. APPENDIX TABLE 3
Potential Components of the Comprehensive Eye and Vision Examination for School-age Children
A. Patient History
1. Nature and history of the presenting problem, including chief complaint
2. Visual and ocular history
3. General health history, including prenatal, perinatal, and postnatal history and review of systems, surgical 
and/or head or ocular trauma history, and any vision or ocular treatment
4. Medication reconciliation, including prescription and nonprescription drugs (e.g., over the counter 
medications, supplements, herbal remedies) and documentation of medication allergies
5. Family eye and medical histories
6. Developmental history of the child
7. School performance history
8. Time spent outdoors, on sports activities, and on near work and screen viewing
9. Names of, and contact information for, the patient’s other health care providers
B. Visual Acuity
1. Snellen visual acuity
2. ETDRS visual acuity
C. Refraction




D. Binocular Vision, Ocular Motility, and Accommodation
1. Ocular alignment assessment - distance and near (e.g., cover test, Hirschberg test, Krimsky test, Von Graefe 
phoria, Modified Thorington, Maddox Rod)
2. Ocular motility assessment (e.g., fixation, saccades, pursuits)
3. Near point of convergence
4. Stereopsis (e.g., Random dot stereopsis test)
5. Positive and negative fusional vergence ranges 
6. Accommodative testing (e.g., amplitude, facility, and response)
E. Color Vision Testing
F. Ocular and Systemic Health Assessment
1. Assessment of pupillary responses
2. Visual field evaluation (e.g., confrontation)
3. Evaluation of the ocular anterior segment and adnexa
4. Evaluation of the ocular posterior segment
5. Measurement of intraocular pressure




E. APPENDIX TABLE 4
Partial Listing of Ocular Manifestations of Neurodevelopmental Disorders and Other Syndromes
Neurodevelopmental Disorders Etiology Associated Ocular Manifestations
Aicardi Syndrome Dysgenesis of the corpus callosum Chorioretinal lacunae, optic nerve colobomas, 
optic nerve hypoplasia
Alport Syndrome Irregular synthesis of collagen Fleck retinal dystrophy, anterior lenticonus, 
corneal dystrophy, cataracts
Angelman Syndrome Deletion of maternal genetic material on 
chromosome 15
Strabismus, hypopigmentation of the choroid
Attention Deficit/Hyperactivity Disorder Genetic influences on dopaminergic systems, 
prenatal factors such as maternal use of drugs 
and alcohol
Convergence insufficiency, accommodative 
dysfunction, oculomotor disorders
Autism Spectrum Disorders Unknown; possible link to environmental 
stressors, genetic mutations and inflammatory 
processes
Deficits in visual acuity, stereoacuity and ocular 
alignment; poor saccades and pursuits
Bardet-Biedl Syndrome Mutation in 14 different genes that lead to 
problems with the function of cilia in cell 
structures
Reduced visual acuity, problems with night vision, 
tunnel vision
Batten-Mayou Syndrome Autosomal recessive disorder resulting in 
accumulation of lipids
Lipofuscin accumulation in the retina, optic 
atrophy, macular pigment
Behçet’s Disease Postulated to be episodic hyperactivity of immune 
system
Uveitis, cataracts, optic atrophy, macular edema
Behr Syndrome Autosomal recessive disease resulting in 
progressive deterioration of the nervous system
Optic atrophy, retrobulbar neuritis, nystagmus
Branchial Arch Syndrome Disruption of neural crest cell migration Strabismus, proptosis from poorly formed orbits, 
coloboma of the eyelid
Cerebral Palsy Disorder of movement and posture secondary to 
damage to motor control connections
Strabismus, nystagmus, optic nerve pallor, 
cataracts, myopia, accommodative dysfunction
Cerebro-oculo-facial Syndrome Autosomal recessive disorder resulting in 
defective swallowing mechanism
Microphthalmia, involuntary eye movements, 
congenital cataracts, blepharophimosis
Charot-Marie-Tooth Syndrome Genetic anomaly resulting in progressive muscular 
atrophy
Nystagmus, diminished visual acuity
CHARGE Syndrome Common mutation of chromosome 8 resulting in 
association of multiple systemic defects
Bilateral retinal coloboma involving the optic 
nerve, strabismus, amblyopia
Cri-du-chat Syndrome Deletion of short arm of chromosome 5 Strabismus, hypertelorism, slanting of the 
palpebral fissure
Dandy-Walker syndrome Absence of the cerebellar vermis and dilation of 
fourth ventricle
Papilledema often seen with hydrocephalus, 
ptosis and strabismus secondary to cranial nerve 
palsy
de Lange Syndrome Mutation in genes responsible for chromosomal 
adhesions
Long eyelashes, ptosis telecanthus, alternating 
exotropia
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Neurodevelopmental Disorders Etiology Associated Ocular Manifestations
Down Syndrome Triplicate 21st chromosome Epicanthal folds, upslanting palpebral fissure, 
high refractive error, strabismus, keratoconus, 
blepharitis, accommodative dysfunction/
insufficiency
Dubowitz Syndrome Unknown etiology Strabismus, ptosis, telecanthus, epicanthal folds
Ehlers-Danlos Syndrome Genetic or nutritional defects that have altered the 
biosynthesis of collagen
Lens subluxation, palpebral skin laxity, 
keratoconus, myopia, blue sclera, angiod streaks
Fabry Disease Inherited disorder resulting from an abnormal 
build-up of fat in the blood vessel walls 
throughout the body
Corneal opacity
Fetal Alcohol Syndrome CNS damage secondary to alcohol crossing the 
blood-brain barrier
Telecanthus, strabismus, optic nerve hypoplasia, 
ptosis, microphthalmia
Fragile X Syndrome Gene (FMR1) on the X chromosome  fails to 
allow protein synthesis necessary for neural 
development
Strabismus, astigmatism, amblyopia
Gaucher Disease Lysomal storage disease Strabismus, gaze palsies, corneal clouding, 
pinguecula
Hunter Syndrome Mucopolysaccharidosis l – Lysomal storage 
disease
Corneal clouding, pigmentary degeneration of the 
retina, optic atrophy
Lowe Syndrome Abnormal protein transport within cellular 
membranes
Bilateral congenital cataracts, glaucoma, corneal 
keloids, strabismus
Marfan Syndrome Genetic disorder affecting the body’s connective 
tissue
Severe nearsightedness, dislocated lens, 
detached retina, glaucoma, cataracts
Prader-Willi Syndrome Deletion of paternal genetic material on 
chromosome 15
Strabismus, almond-shaped palpebral fissures, 
myopia
Rett Syndrome Mutation of binding protein (MECP2) that alters 
the development of gray matter
Difficulty maintaining eye contact
Septo-Optic Dysplasia/DeMorsier Syndrome Disorder of early brain/optic nerve development 
associated with a number of environmental and 
genetic factors 
Visual impairment in one or both eyes, nystagmus, 
strabismus
Spina Bifida Incomplete closure of embryonic neural tube Papilledema, nerve palsies, nystagmus, optic 
atrophy
Stickler Syndrome Defective biosynthesis of collagen Myopia, retinal detachments, vitreous anomalies
Usher Syndrome Inherited autosomal recessive trait Retinitis pigmentosa
Williams Syndrome Vast deletion of genes on chromosome 7 Infantile esotropia, anomaly in visual-spatial 
relationship
Source: Adapted from Table 7.1 Rare Neurodevelopmental Disorders in Taub MB, Bartuccio M, Maino DM. 
Visual Diagnosis and Care of the Patient with Special Needs. Lippincott Williams & Wilkins, Philadelphia, PA, 
2012.





ADA Americans with Disabilities Act
AD/HD Attention Deficit/Hyperactivity Disorder
AHRQ Agency for Healthcare Research and Quality
COI Conflict of interest
CE Convergence excess
CI Convergence insufficiency
CLEERE Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error 
CPG Clinical Practice Guideline
CT Computerized tomography





ETDRS Early Treatment of Diabetic Retinopathy Study
G Grams
GAT Goldmann applanation tonometer
GDG Guideline Development Group
GDRG Guideline Development Reading Group
IDEA Individuals with Disabilities Education Act
IEP Individualized Education Program
IOM Institute of Medicine
IOP Intraocular pressure
MRI Magnetic resonance imaging
NPC Near point of convergence
NRA Negative relative accommodation
OCT Optical coherence tomography
PASS Preschool Assessment of Stereopsis with a Smile
PRA Positive relative accommodation
RCT Randomized clinical trial




TOPEL Test of Preschool Early Literacy
VEP Visual evoked potential
UV Ultraviolet
VIP-HIP Vision in Preschoolers-Hyperopia in Preschoolers
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G. SUMMARY OF ACTION STATEMENTS  
A comprehensive pediatric eye and vision examination should include, but is not limited to:  
• Review of the nature and history of the presenting problem, patient and family eye and medical histories, 
including visual, ocular, general health, leisure and sports activities, and developmental and school performance 
history of the child 
• Measurement of visual acuity
• Determination of refractive status
• Assessment of binocular vision, ocular motility, and accommodation 
• Evaluation of color vision (baseline or periodic, if needed, for qualification purposes or if disease related)
• Assessment of ocular and systemic health, including evaluation of pupillary responses, anterior and posterior 
segment, peripheral retina, and evaluation/measurement of intraocular pressure and visual field testing. 
(Consensus)
Cycloplegic retinoscopy is the preferred procedure for the first evaluation of preschoolers. It is necessary to quantify 
significant refractive error in the presence of visual conditions such as strabismus, amblyopia, and anisometropia. 
(Consensus)
Cycloplegic retinoscopy is the preferred procedure for the first evaluation of school-age children. It is necessary 
to quantify significant refractive error in the presence of visual conditions such as strabismus, amblyopia, and 
anisometropia. (Consensus)
Abnormal color vision can affect daily performance of activities involving color discrimination and may interfere 
with or prevent some occupational choices later in life. Children should be tested as soon as possible for color 
vision deficiency and the parents/caregivers of children identified with color vision deficiency should be counseled. 
(Consensus)
Children at risk for learning-related vision problems should be evaluated by a doctor of optometry. (Consensus)
Many children with developmental or intellectual disabilities have undetected and untreated vision problems and 
should receive a comprehensive pediatric eye and vision examination. (Consensus)
At the conclusion of a comprehensive pediatric eye and vision examination, the diagnosis should be explained to 
the patient/parent/caregiver and related to the patient’s symptoms, and a treatment plan and prognosis discussed. 
(Consensus)




Parents/caregivers and children should be educated about potential risks for eye injuries at home, at school, 
and during sports and recreational activities, and advised about safety precautions to decrease the risk of ocular 
injury.193,199 Prevention of eye injuries in children should focus on the use of protective eyewear, parental supervision, 
and include education about both the risks of eye injury and the benefits of protective eyewear.194 (Evidence Grade B/
Strong Recommendation)
All children and their parents/caregivers should be advised about the benefits of the regular use of sunglasses and/
or clear prescription glasses that effectively block at least 99% of UVA and UVB radiation, the use of hats with brims 
when outdoors, and the importance of not looking directly at the sun. (Consensus)
Patients/parents/caregivers should be counseled about the benefits to children’s vision of spending more time 
outdoors.208-211 (Evidence Grade B/Recommendation)
Infants should receive an in-person comprehensive eye and vision assessment between 6 and 12 months of age 
for the prevention and/or early diagnosis and treatment of sight-threatening eye conditions and to evaluate visual 
development.229-231 (Evidence Grade B/Strong Recommendation)
Preschool age children should receive an in-person comprehensive eye and vision examination at least once 
between the ages of 3 and 5 to prevent and/or diagnose and treat any eye or vision conditions that may affect visual 
development.54,107,238,240,241 (Evidence Grade B/Strong Recommendation)
School-age children should receive an in-person comprehensive eye and vision examination before beginning 
school to diagnose, treat and manage any eye or vision conditions.65,115,238,243,244,251 (Evidence Grade B/Strong 
Recommendation)
Children with myopia should have an in-person comprehensive eye and vision examination at least annually, or as 
frequently as recommended (especially until age 12), because of the potential for rapid myopia progression.208,242 
(Evidence Grade B/Strong Recommendation)
School-age children should receive an in-person comprehensive eye and vision examination annually to diagnose, 
treat, and manage eye or vision problems. (Consensus)
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H. GAPS IN RESEARCH EVIDENCE
During the course of the development of this guideline, the Evidence-Based Optometry Guideline Development 
Group identified the following gaps in evidence as potential areas for future research:
• Research to compare the outcomes of vision screenings versus comprehensive eye and vision examinations
• Research to determine the risks and protective factors associated with eye injuries in children in order to design 
appropriate prevention strategies
• Research on the effects and possible interaction of outdoor activity with near work and myopia in children.
VI. METHODOLOGY FOR GUIDELINE DEVELOPMENT
This guideline was developed by the AOA Evidence-Based Optometry Guideline Development Group (GDG). Clinical 
questions to be addressed in the guideline were identified and refined during an initial meeting of the GDG and served 
as the basis for a search of the clinical and research literature. 
An English language search of the medical literature for the eye and vision examination of children birth through 18 
years of age, for the time period January 2005 through October 2016 was conducted by trained researchers. If the 
search did not produce results, the search parameters were extended an additional 5 years.
Search Inclusion Criteria (must meet all): 
1. English Studies
2. Study addresses the clinical question(s)
3. Paper meets the age group being addressed (0 to 18 years for pediatrics) 
4. Searched by question(s) formulated at the AOA Call to Question Meeting attended by the Guideline 
Development Group (GDG)
5. Using all similar and relevant terms as defined by the GDG
Exclusion Criteria (meeting any of the below): 
1. Non-English studies
2. Animal studies
3. Studies outside of the patient age range
4. Studies not addressing any topic of the clinical questions searched




In addition, a review of selected earlier research publications was conducted based on previous versions of this 
guideline. The literature search was conducted using the following electronic databases: 
The literature search resulted in the retrieval of the number of references shown in the following chart.
Final copy 3/3/17 
 2942 
 2943 
All references meeting the criteria were reviewed to determine their relevance to the clinical questions 2944 
addressed in the guideline. Each article was assigned to two clinicians who independently reviewed 2945 
and graded the quality of evidence and the clinical recommendations derived from the article, based 2946 
on a previously defined system for grading quality. If discrepancies were found in the grading results, 2947 
the article was assigned to an independent third reader for review and grading.  2948 
During six articulation meetings (three face-to-face and three using a Webex platform) of the 2949 
Evidence-Based Optometry Guideline Development Reading Group (GDRG), all evidence was 2950 
reviewed and clinical recommendations were developed. The strength level of clinical 2951 
recommendations was based on the quality grade of the research and the potential benefits and 2952 
harms of the procedure or therapy recommended. Where high quality evidence to support a 2953 
recommendation was weak or lacking, a group consensus was required to approve any consensus 2954 
recommendations.  2955 
Review and editing of the draft guideline by the Evidence-Based Optometry GDG required one face- 2956 
to-face meeting and three additional Draft Reading Meetings using a Webex platform. The final Peer 2957 
Review draft was reviewed and approved by the GDG by conference call, then made available for 2958 
peer and public review for 30 days for numerous stakeholders (individuals and organizations). 2959 
Comments were promoted and encouraged. All suggested revisions were reviewed and, if accepted 2960 
by the GDG, incorporated into the guideline. All peer and public comments and all actions (and 2961 
inactions) were recorded. 2962 
Clinical recommendations in this guideline are evidence-based statements regarding patient care that 2963 
are supported by the scientific literature or consensus of professional opinion when no quality 2964 
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All references meeting the criteria were reviewed to determine their relevance to the clinical questions addressed 
in the guideline. Each article was assigned to two clinicians who independently reviewed and graded the quality of 
evidence and the clinical recommendations derived from the article, based on a previously defined system for grading 
quality. If discrepancies were found in the grading results, the article was assigned to an independent third reader for 
review and grading. 
During six articulation meetings (three face-to-face and three using a Webex platform) of the Evidence-Based 
Optometry Guideline Development Reading Group (GDRG), all evidence was reviewed and clinical recommendations 
were developed. The strength level of clinical recommendations was based on the quality grade of the research 
and the potential benefits and harms of the procedure or therapy recommended. Where high quality evidence to 
support a recommendation was weak or lacking, a group consensus was required to approve any consensus 
recommendations. 
Review and editing of the draft guideline by the Evidence-Based Optometry GDG required one face- to-face meeting 
and three additional Draft Reading Meetings using a Webex platform. The final Peer Review draft was reviewed and 
approved by the GDG by conference call, then made available for peer and public review for 30 days for numerous 
stakeholders (individuals and organizations). Comments were promoted and encouraged. All suggested revisions 
were reviewed and, if accepted by the GDG, incorporated into the guideline. All peer and public comments and all 
actions (and inactions) were recorded.
Clinical recommendations in this guideline are evidence-based statements regarding patient care that are supported 
by the scientific literature or consensus of professional opinion when no quality evidence was discovered. The 
guideline will be periodically reviewed for new scientific and clinical evidence within 3-5 years.
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